WO2018229410A1 - Cosmetic compositions comprising natural extracts and uses thereof - Google Patents
Cosmetic compositions comprising natural extracts and uses thereof Download PDFInfo
- Publication number
- WO2018229410A1 WO2018229410A1 PCT/FR2018/051360 FR2018051360W WO2018229410A1 WO 2018229410 A1 WO2018229410 A1 WO 2018229410A1 FR 2018051360 W FR2018051360 W FR 2018051360W WO 2018229410 A1 WO2018229410 A1 WO 2018229410A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pinus
- abies
- extract
- composition
- branch portion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9767—Pinaceae [Pine family], e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Definitions
- the present invention belongs to the field of natural extracts and in particular extracts of branch part. More particularly, the present invention relates to cosmetic compositions comprising such extracts and their uses for combating the signs of skin aging and / or for reinforcing the cutaneous barrier.
- Skin aging is determined by genetic and environmental factors.
- intrinsic aging or chronological, which affects the skin and corresponds to the inevitable modifications of the latter related to the age.
- extrinsic aging which corresponds to clinical, histological and functional changes characteristic of the skin linked to environmental factors such as exposure to the sun, pollution, tobacco, etc., and which thus occupies more especially on exposed areas.
- ROS reactive oxygen species
- Oxidative stress is similar to an excess of free radicals present in the body and excessively produced by various physiological mechanisms or exogenous toxic phenomena such as tobacco, pollution or exposure to UV.
- ROS and free radicals can thus be generated in particular by cellular metabolism, such as mitochondrial respiration, xenobiotic detoxification and solar radiation.
- oxidative stress plays a vital role in aging skin. Indeed, the degradation of lipids and cutaneous proteins under the effect of oxidative stress causes sagging skin, the formation of wrinkles and pigment spots, and a loss of elasticity of the skin and radiance of the complexion. In addition, it was observed that nitric oxide produced in excess during an imbalance of the redox balance, that is to say during a state of oxidative stress, inhibited the synthesis of the proteins necessary for corneification of the epidermis and thus disrupted the barrier function of the skin.
- WO 2007/096089 provides cosmetic or dermatological preparations comprising hydroxymatairsinol for lightening the skin of age spots or for the prevention of tanning of the skin caused especially by UV rays.
- the inventors have developed new cosmetic compositions comprising a branch portion extract enriched in polyphenols, which have interesting antioxidant properties to fight against the signs of skin aging and / or to reinforce the cutaneous barrier.
- the inventors have demonstrated by different methods that the branch portion extract included in the compositions of the invention has antioxidant and antiradical activities superior to the activities of the reference compounds such as pycnogenol, ⁇ -tocopherol (Vitamin E), but also the activities of its main metabolites such as enterolactone and enterodiol.
- the subject of the present invention is therefore a cosmetic composition, in particular for combating the signs of skin aging and / or for reinforcing the cutaneous barrier, comprising a branch portion extract in a cosmetically acceptable medium, in which said part extract of branch comprises at least about 50% by weight of polyphenols and less than about 10% by weight of terpenes, based on the total weight of the extract.
- the subject of the invention is also the cosmetic use of such a composition for combating the signs of skin aging, in particular the formation of wrinkles, sagging skin and loss of radiance of the complexion, due in particular to exposure.
- the invention also relates to a cosmetic process for combating the signs of skin aging, in particular the formation of wrinkles, sagging skin and loss of radiance of the complexion, due in particular to exposure to UV, tobacco and or the pollution and / or to reinforce the cutaneous barrier, comprising the topical application to the skin of the composition according to the invention.
- Figure 1 Evaluation of the antiradical activity of the extract according to the invention (natural extract), hydroxymatairsinol (HMR), enterodiol, enterolactone, and pycnogenol by the DPPH method.
- Figure 2 Evaluation of the antioxidant activity of the extract according to the invention (natural extract) and its main metabolites (enterodiol and enterolactone), expressed in trolox equivalent (square units) and vitamin E (dotted line).
- FIG. 3 Evaluation of the total antioxidant capacity of the extract according to the invention (natural extract), of pycnogenol, and of hydroxymatairsinol (HMR), expressed in millimoles of total antioxidant per gram of product, by PAOT technology. POT ® .
- FIG. 4 Evaluation of the total antioxidant efficacy of the extract according to the invention (natural extract) and of its main metabolites (enterodiol and enterolactone), expressed in millimoles of total antioxidant per gram of product, using PAOT / POT ® .
- the inventors have developed and identified novel compositions comprising a branch portion extract in a cosmetically acceptable medium, wherein said branch portion extract comprises at least about 50% by weight of polyphenols and less than about 10% by weight of terpenes, based on the total weight of the extract.
- the cosmetic composition comprising such a branch portion extract has a high antioxidant and antiradical power and can thus be used in cosmetic applications, in particular to fight against the signs of skin aging and / or to reinforce the barrier skin.
- polyphenols present in the branch portion extract of the invention have an antioxidant and antiradical potency superior to their metabolites, thus illustrating an improved efficacy of the topical route for combating the signs of skin aging and / or strengthening the cutaneous barrier compared to an oral route that metabolizes these polyphenols.
- the branch portion extract according to the invention is obtained by a standard extraction method of a branch portion of the trees, preferably softwoods comprising the following steps: (a) extraction, (b) liquid / solid separation (filtration), (c) concentration, and (d) drying.
- the branch portion extract is a dry extract.
- the term "branch portion” refers to that portion of the tree excluding the trunk.
- Part of a branch includes, for example, leaves, bark, stems, buds, and knots of wood.
- the "branch part” excludes the nodes of the wood.
- the "branch part” comprises the leaves, the bark, the stems and the buds, and is in particular devoid of knots of the wood.
- the branch portion extract of the cosmetic compositions according to the invention comprises at least about 50%, 60%, 70%, preferably 80%, more preferably at least about 90% by weight of polyphenols and less than about 10%, 8%, 6%, preferably less than about 5% by weight of terpenes, based on the total weight of the extract.
- Polyphenols are a structural class of chemical compounds characterized by the presence of large numbers of phenol structural units. Polyphenols can also be called "lignan” when they are present in plants. As an example of polyphenol or lignane present in softwoods, the following can be mentioned:
- HMR hydroxymatairsinol
- the polyphenols of the branch portion extract according to the invention are selected from the group consisting of hydroxymatairsinol (HMR), lariciresinol, secoisolariciresinol and their epimers.
- HMR hydroxymatairsinol
- lariciresinol lariciresinol
- secoisolariciresinol epimers
- epimer refers to diastereoisomers which differ in configuration by a single stereogenic center.
- diastereoisomer refers to a class of non-superimposable stereoisomers without a mirror image of another.
- epimeres of hydroxymatairsinol denote the diastereoisomers 7S, 8R, 8'R and 7R, 8R, 8'R as illustrated in the following formula:
- the branch portion extract according to the invention comprises:
- the branch portion extract of the cosmetic compositions according to the invention having an improved antioxidant effect is enriched in polyphenols compared to terpenes, and in particular comprises less than about 10% by weight of terpenes, based on the total weight of the terpenes. 'extract.
- Terpenes are a large, diverse class of organic compounds, produced by various plants, especially softwoods.
- the terpenes are derived by biosynthesis from isoprene units of molecular formula represented by the following formula:
- terpenes present in softwoods o-guaicol, terpin hydrate, vanillin, 2,5-dimethylbenzenebutanoic acid, conifeyl alcohol, tumérone, juvabione, dehydrojuvabione, manol, and eucalyptol (1,8-cineol) can be mentioned.
- the branch portion extract of the cosmetic compositions according to the invention may further comprise any other compound present in softwoods in a small amount such as the terpenes as mentioned above, and, typically, eucalyptol (1,8- cineol).
- eucalyptol is known for its toxicity, it is preferably present in small amounts, preferably less than about 10% by weight, more preferably less than about 2, and more preferably less than about 1% by weight. relative to the total weight of the extract.
- the branch portion extract comprises less than 1% by weight of eucalyptol, based on the total weight of the extract.
- the branch portion extract of the cosmetic composition according to the invention is a tree extract selected from Abies alba, Picea abies, Betula pendula, Pinus sylvestris, Abies sibirica, Pinus sibirica, Abies balsamea , Thuja occidentalis, Northern white-cedar, Pinus cembra, Pseudotsuga menziesii, Larix decidua, Picea glauca, Picea mariana, Picea pingens, Abies pectinata, Abies lasiocarpa, Pinus banksiana, Pinus nigra, Pinus pinaster, Pinus resinosa, Larix lariciana, Larix sibirica , Thuja plicata, Fagus sylvatica, Populus alba, Populus nigra, Populus tremula, Populus tremulus, Tsuga hetewphylla, Pinus cont
- the branch portion extract is derived from at least one softwood, preferably selected from Abies alba, Picea abies, Pinus sylvestris, Abies sibirica, Pinus sibirica, Abies balsamea, Thuja occidentalis, Northern white- cedar, Pinus cembra, Pseudotsuga menziesii, Larix decidua, Picea glauca, Picea mariana, Picea pingens, Abies pectinata, Abies lasiocarpa, Pinus banksiana, Pinus nigra, Pinus pinaster, Pinus resinosa, Larix lariciana, Larix sibirica, Thuja plicata, Tsuga hetewphylla, Pinus contorta, Juniperus virginiana, and their mixtures. More preferably, the branch portion extract is a branch portion to Abies alba and / or Picea abies.
- the cosmetic composition comprises a branch portion extract as described above in a cosmetically acceptable medium.
- This composition comprising such an extract is therefore particularly suitable for combating the signs of cutaneous aging and / or reinforcing the cutaneous barrier.
- the branch portion extract as described in the present application is an active ingredient of the cosmetic composition.
- the branch portion extract as described in the present application is the sole active ingredient of the cosmetic composition.
- the branch portion extract is therefore not used in the cosmetic composition as a simple excipient, for example by playing a possible role of stabilizer of the cosmetic composition by virtue of its antioxidant properties.
- the branch part extract plays a role of principle or active ingredient in the cosmetic composition by providing it with the antioxidant and antiradical properties useful for combating the signs of skin aging and / or to strengthen the skin barrier.
- the composition according to the invention comprises at least about 0.1, preferably at least about 1, at least about 5, at least about 10, and even more preferably between about 10% and 50%. weight of the branch portion extract as described above with respect to the total weight of the composition.
- Cosmetically acceptable medium means a medium compatible with the skin and the mucous membranes, that is to say a non-toxic medium tolerated by the subject which, for example, does not generate tingling, irritation, allergic response or redness inconsistent with cosmetic use.
- the cosmetically acceptable medium of a composition according to the invention may comprise any excipient known to those skilled in the art and adapted to the type of application of the composition.
- quaternary ammoniums such as benzalkonium chloride; phenoxyethanol; benzyl alcohol; diazolidinylurea; parabens, such as methylparaben, propylparaben or butylparaben; benzoic acid and its sodium or potassium salts such as sodium benzoate; sorbic acid and its sodium or potassium salts such as potassium sorbate; mercurial derivatives such as phenylmercury salts (acetate, borate or nitrate) or thiomersal; or their mixtures.
- humectants mention may in particular be made of glycerine and sorbitol.
- propenetrating agents mention may in particular be made of propylene glycol, dipropylene glycol, propylene glycol dipelargonate, lauroglycol and ethoxydiglycol.
- oils in particular mineral oils (vaseline oil), oils of vegetable origin (avocado oil, soybean), oils of animal origin (lanolin), synthetic oils (perhydrosqualene), silicone oils (cyclomethicone) and fluorinated oils (perfluoropolyethers).
- mineral oils vaseline oil
- oils of vegetable origin oils of vegetable origin
- lanolin oils of animal origin
- synthetic oils perhydrosqualene
- silicone oils cyclomethicone
- fluorinated oils perfluoropolyethers
- fatty alcohols such as cetyl alcohol, fatty acids, waxes and gums, in particular silicone gums, as fatty substances.
- emulsifiers and coemulsifiers examples include fatty acid esters of polyethylene glycol, such as PEG-100 stearate, PEG-50 stearate and PEG-40 stearate; fatty acid esters of polyol such as glyceryl stearate, sorbitan tristearate and oxyethylenated sorbitan stearates available under the trade names Tween 20 or Tween 60, for example; and their mixtures.
- gelling agents mention may be made of the family of polyacrylamides, such as the mixture Sodium acryloyldimethyltaurate copolymer / isohexadecane / polysorbate 80 sold under the name Simulgel TM 600 by the company Seppic TM, the polyacrylamide / isoparaffin mixture C13-14 / laureth-7, for example for example, the product sold under the name Sepigel 305 TM by the company Seppic TM, the family of acrylic polymers coupled to hydrophobic chains, such as the PEG-150 / decyl / SMDI copolymer sold under the name Aculyn 44 TM (polycondensate comprising less as elements, a polyethylene glycol with 150 or 180 moles of ethylene oxide, decyl alcohol and methylene bis (4-cyclohexyl isocyanate) (SMDI), at 35% by weight in a propylene glycol mixture (39%) and water (26)), the family of modified starches such as modified
- thickening agent mention may be made of polysaccharides such as xanthan gum, gum tragacanth, carrageenans such as ⁇ -carrageenan, ⁇ -carrageenan or i-carrageenan, galactomannans such as locust bean seed meal, guar seed meal or tara seed meal, gellan gum, gum arabic, karaya gum, pectin, starch and its derivatives obtained by esterification or etherification, and tamarind; cellulose derivatives such as methylcellulose, ethylcellulose, ethylmethylcellulose, carboxymethylcellulose, sodium carboxymethylcellulose and hydroxyalkylcelluloses such as hydroxyethylcellulose, hydroxymethylcellulose, hydroxypropylcellulose and hydroxypropylmethylcellulose; and carboxyvinyl polymers of Carbopol ® type.
- carrageenans such as ⁇ -carrageenan, ⁇ -carrageenan or i-carrageenan
- galactomannans such as loc
- the administration of the cosmetic composition may be carried out orally, topically, parenterally, subcutaneously, epicutaneously, intradermally, transdermally, intramuscularly, enterally, intranasally, intrasfinctively or by nasal inhalation, preferably topically.
- the cosmetic composition is a topical or dermatological composition.
- the composition according to the invention can also be called a dermo-cosmetic composition.
- This topical composition can therefore be in any form suitable for topical application to the skin. It is thus envisaged compositions in the form of solutions, lotions, gels, ointments, emulsions of liquid or semi-liquid consistency of the milk type, obtained by dispersion of a fatty phase in an aqueous phase (H / E) or conversely (W / O), or powders, soaked swabs, sprays, suspensions or emulsions of soft, semi-liquid or solid consistency of the cream, ointment or micro-emulsion, micro-capsule type , microparticles or vesicular dispersions of ionic and / or nonionic type. It can also be in the form of microspheres or nanospheres or lipid or polymeric vesicles or in the form of polymeric patches and hydrogel
- the topical cosmetic composition is in the form of a gel, a lotion, or a cream.
- the cosmetic composition further comprises an anti-aging active ingredient.
- anti-aging active agents include: ascorbic acid, its salts, its ethers and its esters, especially ascorbyl glucoside; adenosine; ribose; honey extracts; proteins and glycoproteins, extracted in particular from sweet almonds; hydrolysed vegetable proteins, in particular derived from rice, hibiscus seeds or lupine; polypeptides and dipeptide such as carcinine hydrochloride, pentapeptide-4 palmitoyl (Pal-Lys-Thr-Thr-Lys-Ser) and palmitoyl tripeptide-38 sold for example by Sederma under the trade names Matrixyl ® 3000 and Matrixyl ® Synthe'6, respectively, the palmitoyl tripeptide-8 marketed by LUCAS MEYER under
- composition according to the invention may further comprise at least one tensor polymer, that is to say able to stretch the skin by mechanical action and thus reduce the appearance of wrinkles and fine lines.
- tensor polymer may be a synthetic or natural polymer, in particular a polysaccharide, especially an extract of seaweed or marine plankton or a vegetable gum.
- the cosmetic composition of the invention is adapted to fight against the signs of skin aging and / or to reinforce the cutaneous barrier.
- the signs of skin aging result, for example, in the formation of wrinkles, sagging skin, loss of radiance of the complexion. These signs may be due to factors intrinsic to age but also by extrinsic factors such as UV exposure, tobacco, and pollution.
- the present invention therefore also relates to the use of a composition as defined above for combating the signs of skin aging, in particular the formation of wrinkles, sagging skin and loss of radiance of the complexion, due in particular to exposure to UV, tobacco and / or pollution and / or to reinforce the skin barrier.
- the present invention also relates to a cosmetic method for combating the signs of skin aging, in particular the formation of wrinkles, sagging skin and loss of radiance of the complexion, due in particular to exposure to UV, tobacco and / or to pollution and / or to reinforce the cutaneous barrier, comprising the topical application to the skin of the composition as defined above.
- This composition can be applied one or more times a day, for example morning and / or evening on the areas to be treated.
- the branch part extract obtained above is formulated in the cosmetic compositions according to the invention by any method known to those skilled in the art for formulating cosmetic compositions.
- those skilled in the art will be able to adapt the cosmetically acceptable medium in which the branch part extract will be added in order to obtain the type of formulation desired.
- the free radical DPPH has a violet color which becomes yellow when it is reduced in the presence of radical compounds.
- the intensity of the color is inversely proportional to the antiradical activity of the compounds tested.
- Various dilutions of bee samples dissolved in methanol were added to 3.9 ml of a methanolic solution of DPPH-6, 1x10 -5 M.
- the initial true DPPH concentration (C DPPH) in the medium of The reaction was calculated using a standard curve and the bleaching of DPPH was monitored at 517 nm (spectrophotometer) for 30 minutes against a blank sample consisting of all reagents except DPPH.
- HMR hydroxymatairsinol
- enterodiol enterolactone
- pycnogenol® extract of French maritime pine bark, reference antioxidant compound
- the antiradical activity is expressed as an EC50 value (the EC50 value most s small corresponds to the strongest antioxidant activity).
- the antioxidant activity of the branch portion extract according to the invention is greater than that of HMR, enterodiol, enterolactone, and pycnogenol.
- the total antioxidant activity of the extract according to the invention derives from its capacity to inhibit the radical ABTS + , obtained from ABTS (ammonium salt of 2,2'-azinobis acid). ethylbenzothiazolin-6-ulfonic)) compared to a reference antioxidant compound (pycnogenol®, ⁇ -tocopherol, Trolox) and its metabolites (enterodiol and enterolactone).
- the ABTS cationic radical (ABTS + ) was produced by reacting a stock solution of 7 mM ABTS with 2.45 mM potassium persulfate and allowing the mixture to stand in dim light at room temperature for 12 minutes. h before use.
- the ABTS ⁇ + solution was then diluted with PBS (phosphate buffered saline) (pH 7.4) to an absorbance of 0.5 at 734 nm and equilibrated at 30 ° C.
- the natural extract according to the invention shows the smallest EC50 value (concentration effective to eliminate 50% of ABTS at equilibrium) with a value of 0.020 mg / ml in this test, as indicated in the Table. 1 below.
- Table 1 EC50 values obtained in the TEAC test
- Figure 2 highlights the striking divergence in antioxidant efficacy between the branch part extract and its major metabolites.
- the antioxidant activity of 1 g of the natural extract is equivalent to 1.07 g of trolox (square units) and 1.53 g of vitamin E (dotted line) while the antioxidant activity of 1 g of of enterolactone is equivalent to 0.13 g of trolox (square units) and 0.19 g of vitamin E (dotted), and the antioxidant activity of 1 g of enterodiol is equivalent to 0.15 g of trolox ( square patterns) and 0.22 g of vitamin E (dotted line).
- Measurement of antioxidant capacity by the ORAC method is based on the detection of the fluorescence of a fluorescein drop (FL) by its reaction with the peroxyl ROO * radical, in a food matrix containing antioxidant compounds.
- the fluorescence was read at an excitation wavelength of 485 nm and at an emission filter of 528 nm.
- the AAPH solution and FL were prepared in a 75 mM phosphate buffer solution, pH 7.4.
- the control of this reaction is trolox which is also prepared in the same buffer.
- Six different amounts (10, 20, 35, 50, 70, 80 ⁇ ) of product at a concentration of 0.5 mg / L were placed in the wells of a microplate with the FL and adjusted to the same volume with the solution. buffer (80 ⁇ ).
- the antioxidant activity of 1 gram of the branch part extract is respectively equivalent to the total antioxidant power of 2,400 ⁇ of trolox, 1,300 ⁇ of vitamin C, 1,200 ⁇ of vit. E (tocopherol), and 310 ⁇ of ⁇ -carotene.
- the antioxidant activity of the branch part extract is much greater than the antioxidant activity of 1 g of pycnogenol, 1 g of hydroxymatairsinol (HMR) and 1 g of the metabolites of the natural extract (enterodiol and enterolactone).
- PAOT / POT® Total Antioxidant / Total Oxidative Power
- the overall antioxidant efficacy of the natural extract according to the invention (10.31 mmol / g in antioxidant equivalents) is, against all odds, better than that of pycnogenol (8.82 mmol / g in equivalents antioxidant), and HMR (4.99 mmol / g in antioxidant equivalents).
- Table 3 summarizes the antioxidant activity values of the natural extract, pycnogenol, and HMR compared to reference antioxidant compounds, namely, vitamin E (tocopherol), trolox, and ⁇ -carotene.
- the branch part extract shows the best antioxidant activity among the products tested. Indeed, 1 gram of branch part extract according to the invention is the equivalent in terms of antioxidant efficacy of 2.2 g of vitamin E, 1.29 g of trolox, and 5.53 g of ⁇ -carotene.
- FIG. 4 underlines the divergence in terms of effectiveness between the branch part extract according to the invention and its main metabolites in this test, expressed in millimoles of total antioxidant per gram of product (measurement of the overall antioxidant characteristic of products tested, the highest value corresponds to the best antioxidant efficacy).
- the inventors have unexpectedly shown that the total antioxidant efficacy of the branch part extract (10.31 mmol / g in antioxidant equivalents) was at least ten times greater than the antioxidant efficacy of its metabolites ( enterodiol (1.07 mmol / g antioxidant equivalents) and enterolactone (1.06 mmol / g antioxidant equivalents)).
- the inventors have demonstrated that the branch part extract according to the invention has a higher antioxidant activity compared to the activities of the reference compounds such as pycnogenol, -tocopherol (Vitamin E), and trolox (analog of Vitamin E), thus demonstrating improved cosmetic efficacy for treating the signs of skin aging and / or for reinforcing the cutaneous barrier.
- the reference compounds such as pycnogenol, -tocopherol (Vitamin E), and trolox (analog of Vitamin E)
- the branch portion extract according to the invention has superior antioxidant activity compared to of its main metabolites (enterolactone and enterodiol), thus demonstrating improved efficacy for topical administration of the cosmetic composition that avoids the processes of metabolizing the active ingredients.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to a cosmetic composition comprising a branch portion extract comprising at least approximately 50 wt % of polyphenols and less than approximately 10 wt % of terpenes, relative to the total weight of the extract, in a cosmetically acceptable medium. The invention also relates to the use of such a cosmetic composition for combatting the signs of skin ageing and/or for reinforcing the skin barrier.
Description
COMPOSITIONS COSMETIQUES COMPRENANT DES EXTRAITS NATURELS ET COSMETIC COMPOSITIONS COMPRISING NATURAL EXTRACTS AND
LEURS UTILISATIONS THEIR USES
DOMAINE TECHNIQUE DE L'INVENTION TECHNICAL FIELD OF THE INVENTION
La présente invention appartient au domaine des extraits naturels et notamment des extraits de partie de branche. Plus particulièrement, la présente invention concerne des compositions cosmétiques comprenant de tels extraits et leurs utilisations pour lutter contre les signes du vieillissement cutané et/ou pour renforcer la barrière cutanée. The present invention belongs to the field of natural extracts and in particular extracts of branch part. More particularly, the present invention relates to cosmetic compositions comprising such extracts and their uses for combating the signs of skin aging and / or for reinforcing the cutaneous barrier.
ARRIERE-PLAN TECHNOLOGIQUE DE L'INVENTION BACKGROUND OF THE INVENTION
Le vieillissement cutané est déterminé par des facteurs génétiques et environnementaux. On distingue d'une part le vieillissement intrinsèque, ou chronologique, qui affecte la peau et correspond aux modifications inévitables de cette dernière liée à l'âge. On distingue d'autre part le vieillissement extrinsèque qui correspond à des modifications cliniques, histologiques, et fonctionnelles caractéristiques de la peau liées à des facteurs environnementaux telles que l'exposition solaire, la pollution, le tabac, etc., et qui siège donc plus particulièrement sur les zones exposées. Skin aging is determined by genetic and environmental factors. One distinguishes on the one hand the intrinsic aging, or chronological, which affects the skin and corresponds to the inevitable modifications of the latter related to the age. On the other hand, there is extrinsic aging, which corresponds to clinical, histological and functional changes characteristic of the skin linked to environmental factors such as exposure to the sun, pollution, tobacco, etc., and which thus occupies more especially on exposed areas.
Ces deux processus de vieillissement sont étroitement associés et dans les deux cas, la production d'espèces oxygénées réactives (ROS), conduisant à un stress oxydant est un élément déterminant du vieillissement de la peau. Le stress oxydant s'apparente à un excès de radicaux libres présents dans l'organisme et produits excessivement par divers mécanismes physiologiques ou phénomènes toxiques exogènes tels que le tabac, la pollution ou l'exposition aux UV. Ces ROS et radicaux libres peuvent ainsi être notamment générés par le métabolisme cellulaire, tel que la respiration mitochondriale, la détoxification xénobiotique et le rayonnement solaire. These two aging processes are closely associated and in both cases, the production of reactive oxygen species (ROS), leading to oxidative stress is a determining element of aging of the skin. Oxidative stress is similar to an excess of free radicals present in the body and excessively produced by various physiological mechanisms or exogenous toxic phenomena such as tobacco, pollution or exposure to UV. These ROS and free radicals can thus be generated in particular by cellular metabolism, such as mitochondrial respiration, xenobiotic detoxification and solar radiation.
En principe, la production physiologique des radicaux libres est maîtrisée par les systèmes de défense cellulaires. Toutefois, ceux-ci peuvent être affectés par différents facteurs tels qu'un déficit en antioxydants ou une baisse de l'activité des enzymes antioxydantes ou
encore par la surproduction de ROS et de radicaux libres, conduisant ainsi à un déséquilibre de la balance redox et donc à un état de stress oxydant. In principle, the physiological production of free radicals is controlled by cellular defense systems. However, these may be affected by various factors such as antioxidant deficiency or decreased activity of antioxidant enzymes or again by the overproduction of ROS and free radicals, leading to an imbalance of the redox balance and thus to a state of oxidative stress.
Il est largement admis que le stress oxydant joue un rôle essentiel dans le vieillissement de la peau. En effet, la dégradation des lipides et protéines cutanées sous l'effet du stress oxydant entraîne un relâchement cutané, la formation de rides et de taches pigmentaires, et une perte d'élasticité de la peau et d'éclat du teint. En outre, il a été observé que le monoxyde d'azote produit en excès lors d'un déséquilibre de la balance redox, c'est-à-dire au cours d'un état de stress oxydant, inhibait la synthèse des protéines nécessaires à la cornéification de l'épiderme et perturbait ainsi la fonction barrière de la peau. It is widely accepted that oxidative stress plays a vital role in aging skin. Indeed, the degradation of lipids and cutaneous proteins under the effect of oxidative stress causes sagging skin, the formation of wrinkles and pigment spots, and a loss of elasticity of the skin and radiance of the complexion. In addition, it was observed that nitric oxide produced in excess during an imbalance of the redox balance, that is to say during a state of oxidative stress, inhibited the synthesis of the proteins necessary for corneification of the epidermis and thus disrupted the barrier function of the skin.
On comprend ainsi mieux l'intérêt de disposer de moyens pour protéger efficacement la peau vis-à-vis du stress oxydant. WO 2007/096089 propose des préparations cosmétiques ou dermatologiques comprenant de l'hydroxymatairésinol pour éclaircir la peau des taches de vieillesses ou pour la prévention du bronzage de la peau causée notamment par les rayons UV. It is thus better understood that it is advantageous to have means for effectively protecting the skin against oxidative stress. WO 2007/096089 provides cosmetic or dermatological preparations comprising hydroxymatairsinol for lightening the skin of age spots or for the prevention of tanning of the skin caused especially by UV rays.
US 2005/0169947 propose des formulations cosmétiques à base de lignanes ayant un effet antioxydant, comprenant notamment de l'hydroxymatairésinol, du laricirésinol, ou du sécoisolaricirésinol. US 2005/0169947 proposes cosmetic formulations based on lignans having an antioxidant effect, including in particular hydroxymatairsinol, lariciresinol, or secoisolariciresinol.
Toutefois, il subsiste un besoin de développer de nouvelles compositions cosmétiques permettant de lutter efficacement contre les signes du vieillissement cutané et/ou de renforcer la barrière cutanée. However, there remains a need to develop new cosmetic compositions that effectively fight against the signs of skin aging and / or strengthen the skin barrier.
RESUME DE L'INVENTION SUMMARY OF THE INVENTION
Dans ce contexte les inventeurs ont développé de nouvelles compositions cosmétiques comprenant un extrait de partie de branche enrichi en polyphénols, qui présentent des propriétés antioxydantes intéressantes pour lutter contre les signes du vieillissement cutané et/ou pour renforcer la barrière cutanée. En particulier, les inventeurs ont démontré par différentes méthodes que l'extrait de partie de branche compris dans les compositions de l'invention avait des activités antioxydantes et antiradicalaires supérieures aux activités des
composés de référence tels que le pycnogénol, Γα-tocophérol (Vitamine E), mais aussi aux activités de ses principaux métabolites tels que l'entérolactone et l'entérodiol. In this context the inventors have developed new cosmetic compositions comprising a branch portion extract enriched in polyphenols, which have interesting antioxidant properties to fight against the signs of skin aging and / or to reinforce the cutaneous barrier. In particular, the inventors have demonstrated by different methods that the branch portion extract included in the compositions of the invention has antioxidant and antiradical activities superior to the activities of the reference compounds such as pycnogenol, Γα-tocopherol (Vitamin E), but also the activities of its main metabolites such as enterolactone and enterodiol.
La présente invention a donc pour objet une composition cosmétique, en particulier pour lutter contre les signes du vieillissement cutané et/ou pour renforcer la barrière cutanée, comprenant un extrait de partie de branche dans un milieu cosmétiquement acceptable, dans laquelle ledit extrait de partie de branche comprend au moins environ 50 % en poids de polyphénols et moins d'environ 10 % en poids de terpènes, par rapport au poids total de l'extrait. The subject of the present invention is therefore a cosmetic composition, in particular for combating the signs of skin aging and / or for reinforcing the cutaneous barrier, comprising a branch portion extract in a cosmetically acceptable medium, in which said part extract of branch comprises at least about 50% by weight of polyphenols and less than about 10% by weight of terpenes, based on the total weight of the extract.
L'invention a aussi pour objet l'utilisation cosmétique d'une telle composition pour lutter contre les signes du vieillissement cutané, notamment la formation de rides, le relâchement cutané et la perte d'éclat du teint, dus en particulier à l'exposition aux UV, au tabac et/ou à la pollution et/ou pour renforcer la barrière cutanée. The subject of the invention is also the cosmetic use of such a composition for combating the signs of skin aging, in particular the formation of wrinkles, sagging skin and loss of radiance of the complexion, due in particular to exposure. UV, tobacco and / or pollution and / or to reinforce the skin barrier.
L'invention a également pour objet un procédé cosmétique pour lutter contre les signes du vieillissement cutané, notamment la formation de rides, le relâchement cutané et la perte d'éclat du teint, dus en particulier à l'exposition aux UV, au tabac et/ou à la pollution et/ou pour renforcer la barrière cutanée, comprenant l'application topique sur la peau de la composition selon l'invention. The invention also relates to a cosmetic process for combating the signs of skin aging, in particular the formation of wrinkles, sagging skin and loss of radiance of the complexion, due in particular to exposure to UV, tobacco and or the pollution and / or to reinforce the cutaneous barrier, comprising the topical application to the skin of the composition according to the invention.
LEGENDE DES FIGURES LEGEND OF FIGURES
Figure 1 : Evaluation de l'activité antiradicalaire de l'extrait selon l'invention (extrait naturel), de l'hydroxymatairésinol (HMR), de l'entérodiol, de l'entérolactone, et du pycnogénol par la méthode DPPH. Figure 1: Evaluation of the antiradical activity of the extract according to the invention (natural extract), hydroxymatairsinol (HMR), enterodiol, enterolactone, and pycnogenol by the DPPH method.
Figure 2 : Evaluation de l'activité antioxydante de l'extrait selon l'invention (extrait naturel) et de ses principaux métabolites (entérodiol et entérolactone), exprimée en équivalent trolox (motifs carrés) et vitamine E (pointillés). Figure 2: Evaluation of the antioxidant activity of the extract according to the invention (natural extract) and its main metabolites (enterodiol and enterolactone), expressed in trolox equivalent (square units) and vitamin E (dotted line).
Figure 3 : Evaluation du pouvoir antioxydant total de l'extrait selon l'invention (extrait naturel), du pycnogénol, et de l'hydroxymatairésinol (HMR), exprimé en millimole d'antioxydant total par gramme de produit, par la technologie PAOT/POT®.
Figure 4 : Evaluation de l'efficacité antioxydante totale de l'extrait selon l'invention (extrait naturel) et de ses principaux métabolites (entérodiol et entérolactone), exprimée en millimole d'antioxydant total par gramme de produit, par la technologie PAOT/POT®. DESCRIPTION DETAILLEE DE L' INVENTION FIG. 3: Evaluation of the total antioxidant capacity of the extract according to the invention (natural extract), of pycnogenol, and of hydroxymatairsinol (HMR), expressed in millimoles of total antioxidant per gram of product, by PAOT technology. POT ® . FIG. 4: Evaluation of the total antioxidant efficacy of the extract according to the invention (natural extract) and of its main metabolites (enterodiol and enterolactone), expressed in millimoles of total antioxidant per gram of product, using PAOT / POT ® . DETAILED DESCRIPTION OF THE INVENTION
Les inventeurs ont développé et identifié de nouvelles compositions comprenant un extrait de partie de branche dans un milieu cosmétiquement acceptable, dans laquelle ledit extrait de partie de branche comprend au moins environ 50 % en poids de polyphénols et moins d'environ 10 % en poids de terpènes, par rapport au poids total de l'extrait. Tel que démontré dans les exemples, la composition cosmétique comprenant un tel extrait de partie de branche présente un fort pouvoir antioxydant et antiradicalaire et peut ainsi être utilisé dans des applications cosmétiques, pour lutter notamment contre les signes du vieillissement cutané et/ou renforcer la barrière cutanée. En outre, les polyphénols présents dans l'extrait de partie de branche de l'invention présentent un pouvoir antioxydant et antiradicalaire supérieur à leurs métabolites, illustrant ainsi une efficacité améliorée de la voie topique pour lutter contre les signes du vieillissement cutané et/ou renforcer la barrière cutanée par rapport à une voie orale qui métabolise ces polyphénols. The inventors have developed and identified novel compositions comprising a branch portion extract in a cosmetically acceptable medium, wherein said branch portion extract comprises at least about 50% by weight of polyphenols and less than about 10% by weight of terpenes, based on the total weight of the extract. As demonstrated in the examples, the cosmetic composition comprising such a branch portion extract has a high antioxidant and antiradical power and can thus be used in cosmetic applications, in particular to fight against the signs of skin aging and / or to reinforce the barrier skin. In addition, the polyphenols present in the branch portion extract of the invention have an antioxidant and antiradical potency superior to their metabolites, thus illustrating an improved efficacy of the topical route for combating the signs of skin aging and / or strengthening the cutaneous barrier compared to an oral route that metabolizes these polyphenols.
Extrait de partie de branche Typiquement, l'extrait de partie de branche selon l'invention est obtenu par un procédé d'extraction standard d'une partie de branche des arbres, de préférence des résineux comprenant les étapes suivantes : (a) extraction, (b) séparation liquide/solide (filtration), (c) concentration, et (d) séchage. De préférence, l'extrait de partie de branche est un extrait sec. Tel qu'il est utilisé ici, le terme « partie de branche » désigne la partie de l'arbre excluant le tronc. Une partie de branche comprend par exemple les feuilles, l'écorce, les tiges, les bourgeons, et les nœuds du bois. Dans un mode de réalisation particulier, la « partie de branche » exclut les nœuds du bois. Dans un autre mode de réalisation particulier, la « partie de branche » comprend les feuilles, l'écorce, les tiges et les bourgeons, et est notamment dépourvue de nœuds du bois.
L'extrait de partie de branche des compositions cosmétiques selon l'invention comprend au moins environ 50 %, 60 %, 70 %, de préférence 80 %, de préférence encore au moins environ 90 % en poids de polyphénols et une quantité inférieure à environ 10 %, 8 %, 6 %, de préférence inférieure à environ 5 % en poids de terpènes, par rapport au poids total de l'extrait. Branch Part Extract Typically, the branch portion extract according to the invention is obtained by a standard extraction method of a branch portion of the trees, preferably softwoods comprising the following steps: (a) extraction, (b) liquid / solid separation (filtration), (c) concentration, and (d) drying. Preferably, the branch portion extract is a dry extract. As used herein, the term "branch portion" refers to that portion of the tree excluding the trunk. Part of a branch includes, for example, leaves, bark, stems, buds, and knots of wood. In a particular embodiment, the "branch part" excludes the nodes of the wood. In another particular embodiment, the "branch part" comprises the leaves, the bark, the stems and the buds, and is in particular devoid of knots of the wood. The branch portion extract of the cosmetic compositions according to the invention comprises at least about 50%, 60%, 70%, preferably 80%, more preferably at least about 90% by weight of polyphenols and less than about 10%, 8%, 6%, preferably less than about 5% by weight of terpenes, based on the total weight of the extract.
Les polyphénols sont une classe structurale de composés chimiques caractérisés par la présence de grands multiples de motifs structuraux phénol. Les polyphénols peuvent également être appelés « lignane » quand ils sont présents dans les plantes. A titre d'exemple de polyphénol ou de lignane présent dans les résineux, on peut mentionner les suivants : Polyphenols are a structural class of chemical compounds characterized by the presence of large numbers of phenol structural units. Polyphenols can also be called "lignan" when they are present in plants. As an example of polyphenol or lignane present in softwoods, the following can be mentioned:
- l'hydroxymatairésinol (HMR) répondant à la formule suivante : the hydroxymatairsinol (HMR) corresponding to the following formula:
- le laricirésinol répondant à la formule suivante : - the lariciresinol corresponding to the following formula:
- le sécoisolaricirésinol répondant à la formule suivante : secoisolariciresinol corresponding to the following formula:
- le liovile répondant à la formule suivante :
- the liovile corresponding to the following formula:
De préférence, les polyphénols de l'extrait de partie de branche selon l'invention sont choisis dans le groupe constitué par l'hydroxymatairésinol (HMR), le laricirésinol, le sécoisolaricirésinol et leurs épimères. Preferably, the polyphenols of the branch portion extract according to the invention are selected from the group consisting of hydroxymatairsinol (HMR), lariciresinol, secoisolariciresinol and their epimers.
Tel qu'il est utilisé ici, le terme « épimère » désigne des diastéréoisomères qui diffèrent en termes de configuration par un seul centre stéréogénique. Le terme « diastéréoisomère » désigne une classe de stéréoisomères non superposables, sans image en miroir d'un autre. Par exemple, « les épimères de l'hydroxymatairésinol » désignent les diastéréoisomères 7S, 8R, 8'R et 7R, 8R, 8'R comme illustré dans la formule suivante : As used herein, the term "epimer" refers to diastereoisomers which differ in configuration by a single stereogenic center. The term "diastereoisomer" refers to a class of non-superimposable stereoisomers without a mirror image of another. For example, "epimeres of hydroxymatairsinol" denote the diastereoisomers 7S, 8R, 8'R and 7R, 8R, 8'R as illustrated in the following formula:
Dans un mode de réalisation préféré, l'extrait de partie de branche selon l'invention comprend : In a preferred embodiment, the branch portion extract according to the invention comprises:
- environ 25 à environ 50 % en poids d'hydroxymatairésinol, about 25 to about 50% by weight of hydroxymatairsinol,
- environ 5 à environ 15 % en poids de laricirésinol, et about 5 to about 15% by weight of lariciresinol, and
- environ 5 à environ 15 % en poids de sécoisolaricirésinol, about 5 to about 15% by weight of secoisolariciresinol,
par rapport au poids total de l'extrait. Tel qu'il est utilisé ici, le terme « environ » sera compris par l'homme du métier et variera dans une certaine mesure en fonction du contexte dans lequel il est utilisé. Si certaines utilisations du terme ne sont pas claires pour l'homme du métier en fonction du contexte dans lequel il est utilisé, « environ » signifiera « jusqu'à plus ou moins 10 , de préférence 5 % » du terme particulier.
L'extrait de partie de branche des compositions cosmétiques selon l'invention ayant un effet antioxydant amélioré est enrichi en polyphénols comparativement aux terpènes, et en particulier, comprend moins d'environ 10 % en poids de terpènes, par rapport au poids total de l'extrait. relative to the total weight of the extract. As used herein, the term "about" will be understood by those skilled in the art and will vary to a certain extent depending on the context in which it is used. If certain uses of the term are unclear to those skilled in the art depending on the context in which it is used, "about" will mean "up to plus or minus 10, preferably 5%" of the particular term. The branch portion extract of the cosmetic compositions according to the invention having an improved antioxidant effect is enriched in polyphenols compared to terpenes, and in particular comprises less than about 10% by weight of terpenes, based on the total weight of the terpenes. 'extract.
Les terpènes sont une grande classe diverse de composés organiques, produits par diverses plantes, en particulier les résineux. Les terpènes sont dérivés par biosynthèse à partir de motifs isoprène de formule moléculaire représentés par la formule suivante :
Terpenes are a large, diverse class of organic compounds, produced by various plants, especially softwoods. The terpenes are derived by biosynthesis from isoprene units of molecular formula represented by the following formula:
A titre de principaux terpènes présents dans les résineux, le o-guaicol, l'hydrate de terpine, la vanilline, l'acide 2,5-diméthylbenzènebutanoïque, l'alcool coniféylique, la tumérone, la juvabione, la déshydrojuvabione, le manol, et l'eucalyptol (1,8-cinéol) peuvent être mentionnés. As main terpenes present in softwoods, o-guaicol, terpin hydrate, vanillin, 2,5-dimethylbenzenebutanoic acid, conifeyl alcohol, tumérone, juvabione, dehydrojuvabione, manol, and eucalyptol (1,8-cineol) can be mentioned.
L'extrait de partie de branche des compositions cosmétiques selon l'invention peut en outre comprendre tout autre composé présent dans les résineux en petite quantité tel que les terpènes comme mentionné ci-dessus, et, typiquement, l'eucalyptol (1,8-cinéol). Toutefois, comme l'eucalyptol est connu pour sa toxicité, il est de préférence présent en petites quantités, de préférence inférieures à environ 10 % en poids, de préférence encore inférieures à environ 2 , et mieux encore inférieures à environ 1 % en poids, par rapport au poids total de l'extrait. Dans un mode de réalisation préféré, l'extrait de partie de branche comprend moins de 1 % en poids d'eucalyptol, par rapport au poids total de l'extrait. The branch portion extract of the cosmetic compositions according to the invention may further comprise any other compound present in softwoods in a small amount such as the terpenes as mentioned above, and, typically, eucalyptol (1,8- cineol). However, since eucalyptol is known for its toxicity, it is preferably present in small amounts, preferably less than about 10% by weight, more preferably less than about 2, and more preferably less than about 1% by weight. relative to the total weight of the extract. In a preferred embodiment, the branch portion extract comprises less than 1% by weight of eucalyptol, based on the total weight of the extract.
Dans un mode de réalisation particulier, l'extrait de partie de branche de la composition cosmétique selon l'invention est un extrait d'arbre choisi parmi Abies alba, Picea abies, Betula pendula, Pinus sylvestris, Abies sibirica, Pinus sibirica, Abies balsamea, Thuja occidentalis, Northern white-cedar, Pinus cembra, Pseudotsuga menziesii, Larix decidua, Picea glauca, Picea mariana, Picea pingens, Abies pectinata, Abies lasiocarpa, Pinus banksiana, Pinus nigra, Pinus pinaster, Pinus resinosa, Larix lariciana, Larix sibirica, Thuja plicata, Fagus Sylvatica, Populus alba, Populus nigra, Populus tremula, Populus tremulus, Tsuga hetewphylla, Pinus contorta, Juniperus virginiana, et leurs mélanges.
Dans un mode de réalisation préféré, l'extrait de partie de branche provient d'au moins un résineux, de préférence choisi parmi Abies alba, Picea abies, Pinus sylvestris, Abies sibirica, Pinus sibirica, Abies balsamea, Thuja occidentalis, Northern white-cedar, Pinus cembra, Pseudotsuga menziesii, Larix decidua, Picea glauca, Picea mariana, Picea pingens, Abies pectinata, Abies lasiocarpa, Pinus banksiana, Pinus nigra, Pinus pinaster, Pinus resinosa, Larix lariciana, Larix sibirica, Thuja plicata, Tsuga hetewphylla, Pinus contorta, Juniperus virginiana, et leurs mélanges. De préférence encore, l'extrait de partie de branche est une partie de branche à! Abies alba et/ou de Picea abies. In a particular embodiment, the branch portion extract of the cosmetic composition according to the invention is a tree extract selected from Abies alba, Picea abies, Betula pendula, Pinus sylvestris, Abies sibirica, Pinus sibirica, Abies balsamea , Thuja occidentalis, Northern white-cedar, Pinus cembra, Pseudotsuga menziesii, Larix decidua, Picea glauca, Picea mariana, Picea pingens, Abies pectinata, Abies lasiocarpa, Pinus banksiana, Pinus nigra, Pinus pinaster, Pinus resinosa, Larix lariciana, Larix sibirica , Thuja plicata, Fagus sylvatica, Populus alba, Populus nigra, Populus tremula, Populus tremulus, Tsuga hetewphylla, Pinus contorta, Juniperus virginiana, and mixtures thereof. In a preferred embodiment, the branch portion extract is derived from at least one softwood, preferably selected from Abies alba, Picea abies, Pinus sylvestris, Abies sibirica, Pinus sibirica, Abies balsamea, Thuja occidentalis, Northern white- cedar, Pinus cembra, Pseudotsuga menziesii, Larix decidua, Picea glauca, Picea mariana, Picea pingens, Abies pectinata, Abies lasiocarpa, Pinus banksiana, Pinus nigra, Pinus pinaster, Pinus resinosa, Larix lariciana, Larix sibirica, Thuja plicata, Tsuga hetewphylla, Pinus contorta, Juniperus virginiana, and their mixtures. More preferably, the branch portion extract is a branch portion to Abies alba and / or Picea abies.
Composition cosmétique Cosmetic composition
La composition cosmétique comprend un extrait de partie de branche tel que décrit ci-dessus dans un milieu cosmétiquement acceptable. Cette composition comprenant un tel extrait est donc particulièrement adaptée à la lutte contre les signes de vieillissement cutanée et/ou au renforcement de la barrière cutanée. The cosmetic composition comprises a branch portion extract as described above in a cosmetically acceptable medium. This composition comprising such an extract is therefore particularly suitable for combating the signs of cutaneous aging and / or reinforcing the cutaneous barrier.
Selon un mode préféré de l'invention, l'extrait de partie de branche tel que décrit dans la présente demande est un principe actif de la composition cosmétique. Selon un mode encore plus préféré de l'invention, l'extrait de partie de branche tel que décrit dans la présente demande est le seul principe actif de la composition cosmétique. Selon ces modes de réalisation préférés, l'extrait de partie de branche n'est donc pas utilisé dans la composition cosmétique en tant que simple excipient, par exemple en jouant un rôle éventuel de stabilisateur de la composition cosmétique de par ses propriétés antioxydantes. Au contraire, selon ces modes préférés, l'extrait de partie de branche joue un rôle de principe ou ingrédient actif dans la composition cosmétique en apportant à celle-ci les propriétés antioxydantes et antiradicalaires utiles pour lutter contre les signes du vieillissement cutané et/ou pour renforcer la barrière cutanée. Selon un mode particulier, la composition selon l'invention comprend au moins environ 0,1 , de préférence au moins environ 1 , au moins environ 5 , au moins environ 10 , et de manière encore plus préférée entre environ 10 % et 50 % en poids de l'extrait de partie de branche tel que décrit ci-dessus par rapport au poids total de la composition.
Par milieu cosmétiquement acceptable, on entend un milieu compatible avec la peau et les muqueuses, c'est-à-dire un milieu non toxique toléré par le sujet qui, par exemple, ne génère pas de picotements, d'irritation, de réponse allergique ou de rougeurs incompatibles avec une utilisation cosmétique. According to a preferred embodiment of the invention, the branch portion extract as described in the present application is an active ingredient of the cosmetic composition. According to an even more preferred embodiment of the invention, the branch portion extract as described in the present application is the sole active ingredient of the cosmetic composition. According to these preferred embodiments, the branch portion extract is therefore not used in the cosmetic composition as a simple excipient, for example by playing a possible role of stabilizer of the cosmetic composition by virtue of its antioxidant properties. In contrast, according to these preferred modes, the branch part extract plays a role of principle or active ingredient in the cosmetic composition by providing it with the antioxidant and antiradical properties useful for combating the signs of skin aging and / or to strengthen the skin barrier. According to one particular embodiment, the composition according to the invention comprises at least about 0.1, preferably at least about 1, at least about 5, at least about 10, and even more preferably between about 10% and 50%. weight of the branch portion extract as described above with respect to the total weight of the composition. Cosmetically acceptable medium means a medium compatible with the skin and the mucous membranes, that is to say a non-toxic medium tolerated by the subject which, for example, does not generate tingling, irritation, allergic response or redness inconsistent with cosmetic use.
Le milieu cosmétiquement acceptable d'une composition selon l'invention peut comprendre tout excipient connu de l'homme du métier et adapté au type d'application de la composition. The cosmetically acceptable medium of a composition according to the invention may comprise any excipient known to those skilled in the art and adapted to the type of application of the composition.
On peut citer notamment des séquestrants, des chélatants des antioxydants, des filtres solaires, des conservateurs, des charges, des électrolytes, des humectants, des colorants, des parfums, des huiles essentielles, des actifs cosmétiques, des hydratants, des vitamines, des acides gras essentiels, des sphingolipides, des agents apaisants et protecteurs de la peau tels que l'allantoïne, des agents propénétrants, des émulsionnants, des gélifiants, des agents épaississants, des agents tampons, des excipients lipophiles, des agents délitants, des agents solubles, des agents de compression ou un mélange de ceux-ci. Bien entendu, l'homme du métier veillera à choisir ce ou ces éventuels excipients, et/ou leur quantité, de manière telle que les propriétés avantageuses de la composition selon l'invention ne soient pas, ou substantiellement pas, altérées. Comme conservateurs, on peut citer à titre d'exemple, des ammoniums quaternaires tels que le chlorure de benzalkonium ; le phénoxyéthanol ; l'alcool benzylique ; la diazolidinylurée ; les parabens, tels que le méthylparabène, le propylparabène ou le butylparabène ; l'acide benzoïque et ses sels sodiques ou potassique tels que le benzoate de sodium ; l'acide sorbique et ses sels sodiques ou potassique tels que le sorbate de potassium ; des dérivés mercuriels tels que les sels de phénylmercure (acétate, borate ou nitrate) ou le thiomersal ; ou leurs mélanges. These include sequestering agents, antioxidants chelating agents, sunscreens, preservatives, fillers, electrolytes, humectants, dyes, perfumes, essential oils, cosmetic active agents, moisturizers, vitamins, acids and the like. essential fatty acids, sphingolipids, soothing and skin-protecting agents such as allantoin, propenetrating agents, emulsifiers, gelling agents, thickeners, buffering agents, lipophilic excipients, disintegrating agents, soluble agents, compression agents or a mixture thereof. Of course, those skilled in the art will take care to choose this or these optional excipients, and / or their quantity, such that the advantageous properties of the composition according to the invention are not, or not substantially impaired. As preservatives, there may be mentioned, for example, quaternary ammoniums such as benzalkonium chloride; phenoxyethanol; benzyl alcohol; diazolidinylurea; parabens, such as methylparaben, propylparaben or butylparaben; benzoic acid and its sodium or potassium salts such as sodium benzoate; sorbic acid and its sodium or potassium salts such as potassium sorbate; mercurial derivatives such as phenylmercury salts (acetate, borate or nitrate) or thiomersal; or their mixtures.
Comme agents humectants, on peut citer en particulier, la glycérine et le sorbitol. Comme agents propénétrants, on peut citer en particulier, le propylène glycol, le dipropylène glycol, le propylène glycol dipélargonate, le lauroglycol et l'ethoxydiglycol. As humectants, mention may in particular be made of glycerine and sorbitol. As propenetrating agents, mention may in particular be made of propylene glycol, dipropylene glycol, propylene glycol dipelargonate, lauroglycol and ethoxydiglycol.
Comme matières grasses, on peut citer de manière non limitative les huiles et notamment les huiles minérales (huile de vaseline), les huiles d'origine végétale (huile d'avocat, huile de
soja), les huiles d'origine animale (lanoline), les huiles de synthèse (perhydrosqualène), les huiles siliconées (cyclomethicone) et les huiles fluorées (perfluoropolyethers). On peut aussi utiliser comme matières grasses des alcools gras tels que l'alcool cétylique, des acides gras, des cires et des gommes en particulier les gommes de silicone. As fats, mention may be made in a nonlimiting manner of oils, in particular mineral oils (vaseline oil), oils of vegetable origin (avocado oil, soybean), oils of animal origin (lanolin), synthetic oils (perhydrosqualene), silicone oils (cyclomethicone) and fluorinated oils (perfluoropolyethers). It is also possible to use fatty alcohols such as cetyl alcohol, fatty acids, waxes and gums, in particular silicone gums, as fatty substances.
Comme émulsionnants et coémulsionnants, on peut citer par exemple les esters d'acide gras et de polyéthylène glycol tels que le stéarate de PEG-100, le stéarate de PEG-50 et le stéarate de PEG-40; les esters d'acide gras et de polyol tels que le stéarate de glycéryle, le tristéarate de sorbitane et les stéarates de sorbitane oxyéthylénés disponibles sous les dénominations commerciales Tween 20 ou Tween 60, par exemple; et leurs mélanges. Examples of emulsifiers and coemulsifiers that may be mentioned include fatty acid esters of polyethylene glycol, such as PEG-100 stearate, PEG-50 stearate and PEG-40 stearate; fatty acid esters of polyol such as glyceryl stearate, sorbitan tristearate and oxyethylenated sorbitan stearates available under the trade names Tween 20 or Tween 60, for example; and their mixtures.
Comme gélifiants, on peut citer la famille des polyacrylamides tels que le mélange Sodium acryloyldiméthyltaurate copolymer / isohexadecane / polysorbate 80 vendu sous le nom Simulgel™ 600 par la société Seppic™, le mélange polyacrylamide / isoparaffine C13-14 / laureth-7 comme, par exemple, celui vendu sous le nom de Sepigel 305™ par la société Seppic™, la famille des polymères acryliques couplés à des chaînes hydrophobes tel que le PEG-150 / decyl / SMDI copolymère vendu sous le nom de Aculyn 44™ (polycondensat comprenant au moins comme éléments, un poléthylèneglycol à 150 ou 180 moles d'oxyde d'éthylène, de l'alcool décylique et du méthylène bis(4-cyclohexylisocyanate) (SMDI), à 35 % en poids dans un mélange de propylèneglycol (39 %) et d'eau (26 )), la famille des amidons modifiés tels que l'amidon de pomme de terre modifié vendu sous le nom de Structure Solanace™ ou bien leurs mélanges. As gelling agents, mention may be made of the family of polyacrylamides, such as the mixture Sodium acryloyldimethyltaurate copolymer / isohexadecane / polysorbate 80 sold under the name Simulgel ™ 600 by the company Seppic ™, the polyacrylamide / isoparaffin mixture C13-14 / laureth-7, for example for example, the product sold under the name Sepigel 305 ™ by the company Seppic ™, the family of acrylic polymers coupled to hydrophobic chains, such as the PEG-150 / decyl / SMDI copolymer sold under the name Aculyn 44 ™ (polycondensate comprising less as elements, a polyethylene glycol with 150 or 180 moles of ethylene oxide, decyl alcohol and methylene bis (4-cyclohexyl isocyanate) (SMDI), at 35% by weight in a propylene glycol mixture (39%) and water (26)), the family of modified starches such as modified potato starch sold as Solanace ™ Structure or mixtures thereof.
Comme agent épaississant, on peut citer des polysaccharides tels que la gomme xanthane, la gomme adragante, les carraghénanes tels que les λ-carraghénane, le κ-carraghénane ou le i- carraghénane, les galactomannanes tels que la farine de graines de caroube, la farine de graines de guar ou la farine de graines de tara, la gomme gellane, la gomme arabique, la gomme karaya, les pectines, l'amidon et ses dérivés obtenus par estérification ou éthérification, et le tamarin; des dérivés de cellulose tels que la méthylcellulose, l'éthylcellulose, l'éthylméthylcellulose, la carboxyméthylcellulose, la carboxyméthylcellulose sodique et des hydroxyalkylcelluloses tels que l'hydroxyéthylcellulose, l'hydroxyméthylcellulose, l'hydroxypropylcellulose et l'hydroxypropylméthylcellulose ; et des polymères carboxyvinyliques de type Carbopol®.
L'administration de la composition cosmétique peut être effectuée par voie orale, topique, parentérale, sous-cutanée, épicutanée, intra-dermique, transdermique, intramusculaire, entérale, intranasale, intra-respiratoire ou par inhalation nasale, de préférence par voie topique. As thickening agent, mention may be made of polysaccharides such as xanthan gum, gum tragacanth, carrageenans such as λ-carrageenan, κ-carrageenan or i-carrageenan, galactomannans such as locust bean seed meal, guar seed meal or tara seed meal, gellan gum, gum arabic, karaya gum, pectin, starch and its derivatives obtained by esterification or etherification, and tamarind; cellulose derivatives such as methylcellulose, ethylcellulose, ethylmethylcellulose, carboxymethylcellulose, sodium carboxymethylcellulose and hydroxyalkylcelluloses such as hydroxyethylcellulose, hydroxymethylcellulose, hydroxypropylcellulose and hydroxypropylmethylcellulose; and carboxyvinyl polymers of Carbopol ® type. The administration of the cosmetic composition may be carried out orally, topically, parenterally, subcutaneously, epicutaneously, intradermally, transdermally, intramuscularly, enterally, intranasally, intrasfinctively or by nasal inhalation, preferably topically.
Selon un mode préféré de l'invention, la composition cosmétique est une composition topique ou dermatologique. La composition selon l'invention peut aussi être appelée composition dermo-cosmétique. Cette composition topique peut donc se présenter sous toute forme adaptée à une application topique sur la peau. Il est ainsi envisagé des compositions sous forme de solutions, de lotions, de gels, d'onguents, d'émulsions de consistance liquide ou semi-liquide du type lait, obtenues par dispersion d'une phase grasse dans une phase aqueuse (H/E) ou inversement (E/H), ou de poudres, de tampons imbibes, de sprays, de suspensions ou émulsions de consistance molle, semi-liquide ou solide du type crème, pommade ou encore de micro-émulsions, de micro-capsules, de micro-particules ou de dispersions vésiculaires de type ionique et/ou non ionique. Elle peut également se présenter sous forme de microsphères ou nanosphères ou vésicules lipidiques ou polymériques ou sous forme de patches polymériques et d'hydrogels permettant une libération contrôlée. Ces compositions sont préparées selon les méthodes usuelles. According to a preferred embodiment of the invention, the cosmetic composition is a topical or dermatological composition. The composition according to the invention can also be called a dermo-cosmetic composition. This topical composition can therefore be in any form suitable for topical application to the skin. It is thus envisaged compositions in the form of solutions, lotions, gels, ointments, emulsions of liquid or semi-liquid consistency of the milk type, obtained by dispersion of a fatty phase in an aqueous phase (H / E) or conversely (W / O), or powders, soaked swabs, sprays, suspensions or emulsions of soft, semi-liquid or solid consistency of the cream, ointment or micro-emulsion, micro-capsule type , microparticles or vesicular dispersions of ionic and / or nonionic type. It can also be in the form of microspheres or nanospheres or lipid or polymeric vesicles or in the form of polymeric patches and hydrogels allowing controlled release. These compositions are prepared according to the usual methods.
De préférence, la composition cosmétique topique est sous la forme d'un gel, d'une lotion, ou d'une crème. Dans un mode particulier de l'invention, la composition cosmétique comprend en outre un actif anti-âge. Des exemples de tels actifs anti-âge sont notamment : l'acide ascorbique, ses sels, ses éthers et ses esters, notamment le glucoside d'ascorbyle ; l'adénosine ; le ribose ; les extraits de miel ; les protéines et glycoprotéines, extraites notamment d'amande douce ; les protéines végétales hydrolysées, notamment issues du riz, des graines d'hibiscus ou du lupin ; les polypeptides et les pseudodipeptides, tels que le chlorhydrate de carcinine, le palmitoyl pentapeptide-4 (Pal-Lys-Thr-Thr-Lys-Ser) et le palmitoyl tripeptide-38 commercialisés notamment par SEDERMA sous les dénominations commerciale Matrixyl® 3000 et Matrixyl® Synthe'6, respectivement, le palmitoyl tripeptide-8 commercialisé par la société LUCAS MEYER sous la référence commerciale Nutrazen®, le pentapeptide-18
commercialisé par la société LIPOTEC sous la dénomination commerciale Leuphasyl Solution, le sh-decapeptide-9 commercialisé par la société SANDREAM sous la dénomination commerciale Neoendorphin® et le palmitoyl hexapeptide-52 commercialisé par la société INFINITEC sous la référence commerciale X50 Myocept® Powder ; les silanes tels que le mannuronate de méthylsilanol ; les arabinoxylanes, extraits en particulier de farine de seigle et les galactoarabinanes, issus notamment du mélèze ; l'acide hyaluronique et ses sels ; les polyphénols, extraits en particulier de mimosa ; les alpha-hydroxyacides, dont ceux extraits de citron; les extraits (généralement aqueux) de plantes telles que le trèfle d'eau, la pensée sauvage, la prêle des champs, la Mafane (Acmella oleracea), le chardon aux ânes (Onopordum acanthium), le millefeuille (Achillea millefolium, contenu notamment dans le produit Neurobiox® de la société BASF), l'embelia (Embelia concinna, telle que commercialisée par la société SEPPIC), le figuier de Barbarie (Opuntia ficus indica, commercialisé notamment par MIBELLE AG BIOCHEMISTRY sous la dénomination commerciale AquaCacteen®), la sauge (Salvia officinalis, vendue notamment par PROVITAL GROUP), Vitex negundo (commercialisé notamment par les LABORATOIRES EXPANSCIENCE sous la référence commerciale Neurovity®), la châtaigne, la papaye, l'arganier, l'avoine, le tournesol, la pâquerette, la pivoine ou l'aneth ; les extraits aqueux d'algues et notamment de coralline, de janie rouge, d'Ungaria pinnatifada, d'Alaria esculenta ou de Nannochlorosis oculata ; les huiles essentielles, notamment de myrte ; les gluconates de zinc et/ou de cuivre ; et leurs mélanges. Preferably, the topical cosmetic composition is in the form of a gel, a lotion, or a cream. In a particular embodiment of the invention, the cosmetic composition further comprises an anti-aging active ingredient. Examples of such anti-aging active agents include: ascorbic acid, its salts, its ethers and its esters, especially ascorbyl glucoside; adenosine; ribose; honey extracts; proteins and glycoproteins, extracted in particular from sweet almonds; hydrolysed vegetable proteins, in particular derived from rice, hibiscus seeds or lupine; polypeptides and dipeptide such as carcinine hydrochloride, pentapeptide-4 palmitoyl (Pal-Lys-Thr-Thr-Lys-Ser) and palmitoyl tripeptide-38 sold for example by Sederma under the trade names Matrixyl ® 3000 and Matrixyl ® Synthe'6, respectively, the palmitoyl tripeptide-8 marketed by LUCAS MEYER under the trade name Nutrazen ® , pentapeptide-18 marketed by Lipotec under the trade name Leuphasyl solution, the sh-decapeptide-9 marketed by SANDREAM company under the trade name neoendorphin ® hexapeptide and palmitoyl-52 marketed by Infinitec under the trade reference X50 Myocept ® Powder; silanes such as methylsilanol mannuronate; arabinoxylans, extracted in particular from rye flour and galactoarabinans, especially from larch; hyaluronic acid and its salts; polyphenols, extracted in particular from mimosa; alpha-hydroxy acids, including those extracted from lemon; extracts (generally aqueous) of plants such as water clover, wild pansy, field horsetail, Mafane (Acmella oleracea), donkey thistle (Onopordum acanthium), Yarrow (Achillea millefolium, contained in particular in product Neurobiox ® from BASF), the Embelia (Embelia concinna, as marketed by Seppic), the prickly pear (Opuntia ficus indica, sold especially by MIBELLE BIOCHEMISTRY AG under the trade name AquaCacteen ®), the salvia (Salvia officinalis, sold in particular by PROVITAL GROUP), Vitex negundo (marketed in particular by LABORATORIES EXPANSCIENCE under the trade name Neurovity ® ), chestnut, papaya, argan, oats, sunflower, daisy, peony or dill; aqueous extracts of algae including coralline, red janie, Ungaria pinnatifada, Alaria esculenta or Nannochlorosis oculata; essential oils, including myrtle; zinc gluconates and / or copper; and their mixtures.
Egalement, la composition selon l'invention, peut comprendre en outre au moins un polymère tenseur, c'est-à-dire capable de tendre la peau par action mécanique et de réduire ainsi l'apparence des rides et des ridules. Il peut s'agir d'un polymère synthétique ou naturel, en particulier d'un polysaccharide, notamment d'un extrait d'algue ou de plancton marin ou d'une gomme végétale. Also, the composition according to the invention may further comprise at least one tensor polymer, that is to say able to stretch the skin by mechanical action and thus reduce the appearance of wrinkles and fine lines. It may be a synthetic or natural polymer, in particular a polysaccharide, especially an extract of seaweed or marine plankton or a vegetable gum.
Grâce à ses propriétés antioxydantes et antiradicalaires, la composition cosmétique de l'invention est adaptée pour lutter contre les signes du vieillissement cutané et/ou renforcer la barrière cutanée. Thanks to its antioxidant and antiradical properties, the cosmetic composition of the invention is adapted to fight against the signs of skin aging and / or to reinforce the cutaneous barrier.
Les signes de vieillissement cutané se traduisent, par exemple, par la formation de rides, un relâchement cutané, une perte d'éclat du teint. Ces signes peuvent être dus par des facteurs
intrinsèques liés à l'âge mais aussi par des facteurs extrinsèques tels que l'exposition aux UV, le tabac, et la pollution. The signs of skin aging result, for example, in the formation of wrinkles, sagging skin, loss of radiance of the complexion. These signs may be due to factors intrinsic to age but also by extrinsic factors such as UV exposure, tobacco, and pollution.
La présente invention concerne donc également l'utilisation d'une composition telle que définie ci-dessus pour lutter contre les signes du vieillissement cutané, notamment la formation de rides, le relâchement cutané et la perte d'éclat du teint, dus en particulier à l'exposition aux UV, au tabac et/ou à la pollution et/ou pour renforcer la barrière cutanée. The present invention therefore also relates to the use of a composition as defined above for combating the signs of skin aging, in particular the formation of wrinkles, sagging skin and loss of radiance of the complexion, due in particular to exposure to UV, tobacco and / or pollution and / or to reinforce the skin barrier.
La présente invention concerne aussi un procédé cosmétique pour lutter contre les signes du vieillissement cutané, notamment la formation de rides, le relâchement cutané et la perte d'éclat du teint, dus en particulier à l'exposition aux UV, au tabac et/ou à la pollution et/ou pour renforcer la barrière cutanée, comprenant l'application topique sur la peau de la composition telle que définie ci-dessus. Cette composition peut être appliquée une ou plusieurs fois par jour, par exemple matin et/ou soir sur les zones à traiter. The present invention also relates to a cosmetic method for combating the signs of skin aging, in particular the formation of wrinkles, sagging skin and loss of radiance of the complexion, due in particular to exposure to UV, tobacco and / or to pollution and / or to reinforce the cutaneous barrier, comprising the topical application to the skin of the composition as defined above. This composition can be applied one or more times a day, for example morning and / or evening on the areas to be treated.
Les exemples qui suivent servent à illustrer et montrer d'autres aspects et avantages de l'invention et doivent être considérés non limitatifs. The examples which follow serve to illustrate and show other aspects and advantages of the invention and must be considered as being nonlimiting.
EXEMPLES EXAMPLES
Exemple 1 : Compositions cosmétiques selon l'invention 1. Procédé d'extraction des extraits de partie de branche EXAMPLE 1 Cosmetic Compositions According to the Invention 1. Method for Extracting Branch Part Extracts
54 kg de matière brute naturelle constituée de partie de branche de Picea abies et Abies alba ont été placés dans un extracteur (p. ex. extracteur à fond filtrant de type Lavergne équipé d'une membrane en Nylon) et ont été extraits à l'aide d'éthanol à 15 % dans de l'eau (v/v) à titre de solvant à un rapport matière brute/solvant de 1/10 à 40 °C pendant 24 heures. La séparation liquide/solide a été obtenue à l'aide d'un séchoir centrifuge. L'extrait solide a été placé dans ledit extracteur et a été extrait à l'aide d'éthanol à 15 % dans de l'eau (v/v) à titre de solvant à un rapport matière/solvant de 1/10 à 40 °C pendant 1 heure. La séparation liquide/solide a été obtenue à l'aide d'un séchoir centrifuge. Les deux extraits liquides ont été combinés et la concentration de l'extrait liquide a été réalisée sous vide à 60 °C à l'aide d'un
évaporateur (p. ex. à rideau tombant de type Wiegand). Le séchage des extraits a été réalisé par atomisation à l'aide d'un séchoir-atomiseur en acier inoxydable (p. ex. tour d' atomisation APV de type PSD 52) pour obtenir 3,88 kg d'extrait sec. 2. Procédé de préparation des compositions selon l'invention 54 kg of natural raw material consisting of the branch part of Picea abies and Abies alba were placed in an extractor (eg Lavergne-type filter extractor equipped with a nylon membrane) and extracted with using 15% ethanol in water (v / v) as a solvent at a raw material / solvent ratio of 1/10 to 40 ° C for 24 hours. The liquid / solid separation was obtained using a centrifugal dryer. The solid extract was placed in said extractor and was extracted with 15% ethanol in water (v / v) as a solvent at a material / solvent ratio of 1/10 to 40%. ° C for 1 hour. The liquid / solid separation was obtained using a centrifugal dryer. The two liquid extracts were combined and the concentration of the liquid extract was carried out under vacuum at 60 ° C using a evaporator (eg Wiegand falling curtain). The drying of the extracts was carried out by atomization using a stainless steel spray dryer (eg PSD 52 atomizer tower) to obtain 3.88 kg of solids. 2. Process for preparing the compositions according to the invention
L'extrait de parties de branches obtenu ci-dessus est formulé dans les compositions cosmétiques selon l'invention par toute méthode connue de l'homme du métier permettant de formuler des compositions cosmétiques. En particulier, l'homme du métier saura adapter le milieu cosmétiquement acceptable dans lequel l'extrait de partie de branches sera ajouté afin d'obtenir le type de formulation désiré. The branch part extract obtained above is formulated in the cosmetic compositions according to the invention by any method known to those skilled in the art for formulating cosmetic compositions. In particular, those skilled in the art will be able to adapt the cosmetically acceptable medium in which the branch part extract will be added in order to obtain the type of formulation desired.
Exemple 2 : Evaluation des activités antioxydantes et antiradicalaires des extraits de partie de branche selon l'invention. 2.1. Test DPPH (2,2-diphényl-l-picryrhydrazyle) Example 2 Evaluation of Antioxidant and Anti-Radical Activities of Branch Part Extracts According to the Invention 2.1. DPPH test (2,2-diphenyl-1-picryrhydrazyl)
(Burda et Oleszek: "Antioxidant and anti-radical activities of flavonoids", J. Agric. Food Chem., 2001, 49, 2774-2779). (Burda and Oleszek: "Antioxidant and anti-radical activities of flavonoids", J. Agric Food Chem., 2001, 49, 2774-2779).
Pour étudier l'activité antiradicalaire de l'extrait, le test DPPH a été utilisé. Le radical libre DPPH a une couleur violette qui devient jaune quand il est réduit en présence de composés radicalaires. L'intensité de la couleur, mesurée au spectrophotomètre, est inversement proportionnelle à l'activité antiradicalaire des composés testés. Différentes dilutions d'échantillons d'abeilles dissous dans le méthanol ont été ajoutées à 3,9 ml d'une solution méthanolique de DPPH» à 6,lxl0"5 M. La concentration DPPH exacte initiale (C DPPH») dans le milieu de réaction a été calculée à l'aide d'une courbe d'étalonnage. Le blanchiment du DPPH» a été surveillé à 517 nm (spectrophotomètre) pendant 30 min vis-à-vis d'un échantillon à blanc constitué par l'échantillon contenant tous les réactifs, exception faite du DPPH». L'activité de piégeage des échantillons sur le DPPH» a été exprimée en valeur IC50 (mg/ml) et a été extrapolée à partir d'une courbe dose-réponse. Les tests ont été réalisés en quadruple (n = 4) avec l'extrait selon l'invention, l'hydroxymatairésinol (HMR), l'entérodiol, l'entérolactone, et le pycnogénol® (extrait d'écorce de pin maritime français, composé antioxydant de référence). L'activité antiradicalaire est exprimée en valeur EC50 (la valeur EC50 la plus petite correspond à l'activité antioxydante la plus forte).
Comme illustré sur la Figure 1, l'activité antioxydante de l'extrait de partie de branche selon l'invention est supérieure à celles du HMR, de l'entérodiol, de l'entérolactone, et du pycnogénol. En effet, l'extrait de partie de branche selon l'invention montre contre toute attente, une valeur EC50 (concentration efficace pour réduire 50 % des radicaux DPPH) de 0,13 mg/ml qui est plus petite que la valeur EC50 du HMR (EC50 = 0,20 mg/ml) et du pycnogénol (EC50 = 0,21 mg/ml). To study the antiradical activity of the extract, the DPPH test was used. The free radical DPPH has a violet color which becomes yellow when it is reduced in the presence of radical compounds. The intensity of the color, measured spectrophotometer, is inversely proportional to the antiradical activity of the compounds tested. Various dilutions of bee samples dissolved in methanol were added to 3.9 ml of a methanolic solution of DPPH-6, 1x10 -5 M. The initial true DPPH concentration (C DPPH) in the medium of The reaction was calculated using a standard curve and the bleaching of DPPH was monitored at 517 nm (spectrophotometer) for 30 minutes against a blank sample consisting of all reagents except DPPH. "DPPH specimen trapping activity was expressed as IC50 (mg / mL) and extrapolated from a dose-response curve. carried out in quadruple (n = 4) with the extract according to the invention, hydroxymatairsinol (HMR), enterodiol, enterolactone, and pycnogenol® (extract of French maritime pine bark, reference antioxidant compound The antiradical activity is expressed as an EC50 value (the EC50 value most s small corresponds to the strongest antioxidant activity). As illustrated in FIG. 1, the antioxidant activity of the branch portion extract according to the invention is greater than that of HMR, enterodiol, enterolactone, and pycnogenol. Indeed, the branch portion extract according to the invention shows, against all odds, an EC50 value (concentration effective to reduce 50% of the DPPH radicals) of 0.13 mg / ml which is smaller than the EC50 value of the HMR (EC50 = 0.20 mg / ml) and pycnogenol (EC50 = 0.21 mg / ml).
De plus, l'extrait selon l'invention montre une valeur EC50 de 0,13 mg/ml qui est plus petite que la valeur EC50 de ses métabolites - à savoir, l'entérodiol (EC50 = 0,28 mg/ml) et l'entérolactone (EC50 = 0,30 mg/ml). In addition, the extract according to the invention shows an EC50 value of 0.13 mg / ml which is smaller than the EC50 value of its metabolites - namely, enterodiol (EC50 = 0.28 mg / ml) and enterolactone (EC50 = 0.30 mg / ml).
2.2. Test de la capacité antioxydante en équivalent Trolox (TEAC) 2.2. Trolox Equivalent Antioxidant Capacity Test (TEAC)
(Re R., Pellegrini N., Proteggente A., Pannala A., Yang M., Rice-Evans C: "Antioxidant activity applying an improved ABTS radical cation decolorization assay", Free Radical Biology & Medicine, 1999, 26 (9), 1231-1237). (Re R., Pellegrini N., Proteggente A., Pannala A., Yang M., Rice-Evans C: "Antioxidant activity applying an improved ABTS radical cation decolorization assay", Free Radical Biology & Medicine, 1999, 26 (9 ), 1231-1237).
L'activité antioxydante totale de l'extrait selon l'invention dérive de sa capacité à inhiber le radical ABTS«+, obtenu à partir de l'ABTS (sel d'ammonium de l'acide 2,2'-azinobis(3- éthylbenzothiazoline-6-ulfonique)) comparativement à un composé antioxydant de référence (pycnogénol®, α-tocophérol, Trolox) et à ses métabolites (entérodiol et entérolactone). Le radical cationique ABTS (ABTS«+) a été produit en faisant réagir une solution mère d'ABTS à 7 mM avec 2,45 mM de persulfate de potassium et en laissant le mélange au repos dans la pénombre à température ambiante pendant 12-16 h avant utilisation. La solution d'ABTS ·+ a ensuite été diluée avec du PBS (solution salée à tampon phosphate) (pH 7,4) jusqu'à une absorbance de 0,5 à 734 nm et équilibrée à 30 °C. Des solutions de 200 μΐ d'ABTS«+ et (10, 20, 35, 50, 70, 80 μΐ) de produit (0,5 mg/L) ont été mélangées et ajustées à 300 μΐ avec la solution tampon. Après une incubation de 15 min, la densité optique a été mesurée. Les tests ont été réalisés en quadruple (n = 4). L'efficacité est exprimée en valeur EC50 (la valeur EC50 la plus petite correspond à l'activité antioxydante la plus forte). The total antioxidant activity of the extract according to the invention derives from its capacity to inhibit the radical ABTS + , obtained from ABTS (ammonium salt of 2,2'-azinobis acid). ethylbenzothiazolin-6-ulfonic)) compared to a reference antioxidant compound (pycnogenol®, α-tocopherol, Trolox) and its metabolites (enterodiol and enterolactone). The ABTS cationic radical (ABTS + ) was produced by reacting a stock solution of 7 mM ABTS with 2.45 mM potassium persulfate and allowing the mixture to stand in dim light at room temperature for 12 minutes. h before use. The ABTS · + solution was then diluted with PBS (phosphate buffered saline) (pH 7.4) to an absorbance of 0.5 at 734 nm and equilibrated at 30 ° C. Solutions of 200 μl of ABTS + and (10, 20, 35, 50, 70, 80 μl) of product (0.5 mg / l) were mixed and adjusted to 300 μl with the buffer solution. After a 15 min incubation, the optical density was measured. The tests were performed in quadruple (n = 4). Efficiency is expressed as EC50 value (the lowest EC50 value is the highest antioxidant activity).
Contre toute attente, l'extrait naturel selon l'invention montre la plus petite valeur EC50 (concentration efficace pour éliminer 50 % d'ABTS à l'équilibre) avec une valeur de 0,020 mg/mL dans ce test, comme indiqué dans le Tableau 1 ci-dessous.
Tableau 1 : Valeurs EC50 obtenues dans le test TEAC Unexpectedly, the natural extract according to the invention shows the smallest EC50 value (concentration effective to eliminate 50% of ABTS at equilibrium) with a value of 0.020 mg / ml in this test, as indicated in the Table. 1 below. Table 1: EC50 values obtained in the TEAC test
De plus, la Figure 2 souligne la divergence frappante en termes d'efficacité antioxydante entre l'extrait de partie de branche et ses principaux métabolites. En effet, l'activité antioxydante de 1 g de l'extrait naturel est équivalente à 1,07 g de trolox (motifs carrés) et à 1,53 g de vitamine E (pointillés) tandis que l'activité antioxydante de 1 g de d'entérolactone est équivalente à 0,13 g de trolox (motifs carrés) et à 0,19 g de vitamine E (pointillés), et l'activité antioxydante de 1 g d'entérodiol est équivalente à 0,15 g de trolox (motifs carrés) et à 0,22 g de vitamine E (pointillés). In addition, Figure 2 highlights the striking divergence in antioxidant efficacy between the branch part extract and its major metabolites. In fact, the antioxidant activity of 1 g of the natural extract is equivalent to 1.07 g of trolox (square units) and 1.53 g of vitamin E (dotted line) while the antioxidant activity of 1 g of of enterolactone is equivalent to 0.13 g of trolox (square units) and 0.19 g of vitamin E (dotted), and the antioxidant activity of 1 g of enterodiol is equivalent to 0.15 g of trolox ( square patterns) and 0.22 g of vitamin E (dotted line).
2.3. Test de la capacité d'absorbance des radicaux libres (ORAC) 2.3. Free radical absorbance capacity test (ORAC)
(Ou B., Hampsch-Woodill M. and Prior R. L.: "Development and Validation of an Improved Oxygen Radical Absorbance Capacity Assay Using Fluorescein as the Fluorescent Probe", J. Agric. Food Chem., 2001, 49 (10), 4619-4626) (Or B., Hampsch-Woodill M. and Prior RL: "Development and Validation of an Improved Oxygen Radical Absorbance Capacity Assay Using Fluorescein as Fluorescent Probe", J. Agric., Food Chem., 2001, 49 (10), 4619 -4626)
La mesure de la capacité antioxydante par la méthode ORAC se base sur la détection de la fluorescence d'une goutte de fluorescéine (FL) grâce à sa réaction avec le radical péroxyle ROO*, dans une matrice alimentaire contenant des composés antioxydants. La fluorescence a été lue à une longueur d'onde d'excitation de 485 nm et à un filtre d'émission de 528 nm. La solution AAPH et la FL ont été préparées dans une solution à tampon phosphate à 75 mM, pH 7,4. Le témoin de cette réaction est le trolox qui est également préparé dans le même tampon. Six quantités différentes (10, 20, 35, 50, 70, 80 μΐ) de produit à une concentration de 0,5 mg/L ont été placées dans les puits d'une microplaque avec la FL et ajustées au même volume avec la solution tampon (80 μΐ). Le mélange a été pré-incubé pendant 30 min à 37 °C, avant ajout rapide de la solution AAPH (220 μΐ) à l'aide d'une pipette multicanaux. La microplaque a immédiatement été placée dans le lecteur et la fluorescence enregistrée toutes les 6 min pendant 240 min. Un échantillon à blanc avec la FL et ΓΑΑΡΗ utilisant un tampon phosphate de sodium au lieu de la solution antioxydante a été utilisé. La capacité d'inhibition a été exprimée en équivalents de composé de référence (μΜ), et est quantifiée par intégration de l'aire sous la courbe (AUC) de la fluorescéine. Les tests ont été réalisés en quadruple (n = 4). L'efficacité des échantillons testés est exprimée en unités ORAC de référence par
gramme de produits (la valeur la plus élevée correspond à l'activité antioxydante la plus forte). Les résultats sont illustrés dans le Tableau 2. Measurement of antioxidant capacity by the ORAC method is based on the detection of the fluorescence of a fluorescein drop (FL) by its reaction with the peroxyl ROO * radical, in a food matrix containing antioxidant compounds. The fluorescence was read at an excitation wavelength of 485 nm and at an emission filter of 528 nm. The AAPH solution and FL were prepared in a 75 mM phosphate buffer solution, pH 7.4. The control of this reaction is trolox which is also prepared in the same buffer. Six different amounts (10, 20, 35, 50, 70, 80 μΐ) of product at a concentration of 0.5 mg / L were placed in the wells of a microplate with the FL and adjusted to the same volume with the solution. buffer (80 μΐ). The mixture was preincubated for 30 min at 37 ° C., before rapid addition of the AAPH solution (220 μl) using a multichannel pipette. The microplate was immediately placed in the reader and the fluorescence recorded every 6 min for 240 min. A blank sample with FL and ΓΑΑΡΗ using sodium phosphate buffer instead of the antioxidant solution was used. Inhibitory capacity was expressed in reference compound equivalents (μΜ), and is quantified by integrating the area under the curve (AUC) of fluorescein. The tests were performed in quadruple (n = 4). The effectiveness of the tested samples is expressed in reference ORAC units by gram of products (the highest value corresponds to the strongest antioxidant activity). The results are shown in Table 2.
Tableau 2 : Activité antioxydante de l'extrait de partie de branche selon l'invention, du pycnogénol, du HMR, de l'entérodiol, et de l'entérolactone. Les valeurs sont exprimées en unités équivalentes (μιηοΐ de composé de référence par gramme de produit testé). Table 2: Antioxidant activity of the branch part extract according to the invention, pycnogenol, HMR, enterodiol, and enterolactone. The values are expressed in equivalent units (μιηοΐ of reference compound per gram of product tested).
Les résultats montrent que l'activité antioxydante de 1 gramme de l'extrait de partie de branche est respectivement équivalente au pouvoir antioxydant total de 2 400 μιηοΐ de trolox, de 1 300 μιηοΐ de vitamine C, de 1 200 μιηοΐ de vit. E (tocophérol), et de 310 μιηοΐ de β-carotène. Contre toute attente, l'activité antioxydante de l'extrait de partie de branche est largement supérieure à l'activité antioxydante de 1 g de pycnogénol, 1 g d'hydroxymatairésinol (HMR) et 1 g des métabolites de l'extrait naturel (entérodiol et entérolactone). The results show that the antioxidant activity of 1 gram of the branch part extract is respectively equivalent to the total antioxidant power of 2,400 μιηοΐ of trolox, 1,300 μιηοΐ of vitamin C, 1,200 μιηοΐ of vit. E (tocopherol), and 310 μιηοΐ of β-carotene. Unexpectedly, the antioxidant activity of the branch part extract is much greater than the antioxidant activity of 1 g of pycnogenol, 1 g of hydroxymatairsinol (HMR) and 1 g of the metabolites of the natural extract (enterodiol and enterolactone).
2.4. Test du pouvoir antioxydant total (PAOT®) (stress oxydatif) 2.4. Total antioxidant power test (PAOT®) (oxidative stress)
La technologie PAOT/POT® (Pouvoir antioxydant total/Pouvoir oxydant total) se base sur la nature électrochimique des réactions redox : équilibre entre antioxydants et oxydants [www.ie-antioxydants.com]. Les tests ont été réalisés en quadruple (n = 4). (La valeur la plus élevée correspond à la meilleure efficacité antioxydante). PAOT / POT® (Total Antioxidant / Total Oxidative Power) technology is based on the electrochemical nature of redox reactions: balance between antioxidants and oxidants [www.ie-antioxydants.com]. The tests were performed in quadruple (n = 4). (The highest value is the best antioxidant efficiency).
Comme illustré sur la Figure 3, l'efficacité antioxydante globale de l'extrait naturel selon l'invention (10,31 mmol/g en équivalents antioxydant) est contre toute attente meilleure que celle du pycnogénol (8,82 mmol/g en équivalents antioxydant), et du HMR (4,99 mmol/g en équivalents antioxydant).
Le Tableau 3 ci-dessous résume les valeurs d'activité antioxydante de l'extrait naturel, du pycnogénol, et du HMR par rapport à des composés antioxydants de référence, à savoir, vitamine E (tocophérol), trolox, et β-carotène. Contre toute attente, l'extrait de partie de branche montre la meilleure activité antioxydante parmi les produits testés. En effet, 1 gramme d'extrait de partie de branche selon l'invention est l'équivalent en termes d'efficacité antioxydante de 2,2 g de vitamine E, 1,29 g de trolox, et de 5,53 g of β-carotène. As illustrated in FIG. 3, the overall antioxidant efficacy of the natural extract according to the invention (10.31 mmol / g in antioxidant equivalents) is, against all odds, better than that of pycnogenol (8.82 mmol / g in equivalents antioxidant), and HMR (4.99 mmol / g in antioxidant equivalents). Table 3 below summarizes the antioxidant activity values of the natural extract, pycnogenol, and HMR compared to reference antioxidant compounds, namely, vitamin E (tocopherol), trolox, and β-carotene. Against all odds, the branch part extract shows the best antioxidant activity among the products tested. Indeed, 1 gram of branch part extract according to the invention is the equivalent in terms of antioxidant efficacy of 2.2 g of vitamin E, 1.29 g of trolox, and 5.53 g of β -carotene.
Tableau 3 : Activités antioxydantes par rapport à des composés de référence. Table 3: Antioxidant activities compared to reference compounds.
* gramme de composé de référence par gramme de produit testé * gram of reference compound per gram of product tested
La Figure 4 souligne la divergence en termes d'efficacité entre l'extrait de partie de branche selon l'invention et ses principaux métabolites dans ce test, exprimée en millimole d'antioxydant total par gramme de produit (mesure de la caractéristique antioxydante globale des produits testés ; la valeur la plus élevée correspond à la meilleure efficacité antioxydante). FIG. 4 underlines the divergence in terms of effectiveness between the branch part extract according to the invention and its main metabolites in this test, expressed in millimoles of total antioxidant per gram of product (measurement of the overall antioxidant characteristic of products tested, the highest value corresponds to the best antioxidant efficacy).
En effet, les inventeurs ont montré contre toute attente que l'efficacité antioxydante totale de l'extrait de partie de branche (10,31 mmol/g en équivalents antioxydant) était au moins dix fois supérieure à l'efficacité antioxydante de ses métabolites (entérodiol (1,07 mmol/g en équivalents antioxydant) et entérolactone (1,06 mmol/g en équivalents antioxydant)). Indeed, the inventors have unexpectedly shown that the total antioxidant efficacy of the branch part extract (10.31 mmol / g in antioxidant equivalents) was at least ten times greater than the antioxidant efficacy of its metabolites ( enterodiol (1.07 mmol / g antioxidant equivalents) and enterolactone (1.06 mmol / g antioxidant equivalents)).
2.5. Conclusions 2.5. conclusions
De manière surprenante, les inventeurs ont démontré que l'extrait de partie de branche selon l'invention avait une activité antioxydante supérieure comparée aux activités des composés de référence tels que le pycnogénol, -tocophérol (Vitamine E), et le trolox (analogue de la vitamine E), démontrant ainsi une efficacité cosmétique améliorée pour traiter les signes du vieillissement cutané et/ou pour renforcer la barrière cutanée. Surprisingly, the inventors have demonstrated that the branch part extract according to the invention has a higher antioxidant activity compared to the activities of the reference compounds such as pycnogenol, -tocopherol (Vitamin E), and trolox (analog of Vitamin E), thus demonstrating improved cosmetic efficacy for treating the signs of skin aging and / or for reinforcing the cutaneous barrier.
Les inventeurs ont également démontré de manière inattendue que l'extrait de partie de branche selon l'invention avait une activité antioxydante supérieure comparée aux activités
de ses principaux métabolites (entérolactone et entérodiol), démontrant ainsi une efficacité améliorée pour une administration topique de la composition cosmétique qui évite les processus de métabolisation des actifs.
The inventors have also unexpectedly demonstrated that the branch portion extract according to the invention has superior antioxidant activity compared to of its main metabolites (enterolactone and enterodiol), thus demonstrating improved efficacy for topical administration of the cosmetic composition that avoids the processes of metabolizing the active ingredients.
Claims
1. Composition cosmétique pour lutter contre les signes du vieillissement cutané et/ou pour renforcer la barrière cutanée comprenant un extrait de partie de branche dans un milieu cosmétiquement acceptable, dans laquelle ledit extrait de partie de branche comprend au moins environ 50 % en poids de polyphénols et moins d'environ 10 % en poids de terpènes, par rapport au poids total de l'extrait. A cosmetic composition for combating the signs of skin aging and / or for reinforcing the skin barrier comprising a branch portion extract in a cosmetically acceptable medium, wherein said branch portion extract comprises at least about 50% by weight of polyphenols and less than about 10% by weight of terpenes, based on the total weight of the extract.
2. Composition selon la revendication 1, dans laquelle ledit extrait de partie de branche comprend au moins environ 70 %, de préférence au moins environ 90 % en poids de polyphénols, par rapport au poids total de l'extrait. The composition of claim 1, wherein said branch portion extract comprises at least about 70%, preferably at least about 90% by weight of polyphenols, based on the total weight of the extract.
3. Composition selon la revendication 1 ou 2, dans laquelle les polyphénols sont choisis parmi l'hydroxymatairésinol, le laricirésinol, le sécoisolaricirésinol, et leurs épimères. 3. Composition according to claim 1 or 2, wherein the polyphenols are chosen from hydroxymatairsinol, lariciresinol, secoisolariciresinol, and their epimers.
4. Composition selon l'une quelconque des revendications 1 à 3, dans laquelle ledit extrait de partie de branche comprend : The composition of any one of claims 1 to 3, wherein said branch portion extract comprises:
- environ 25 % à environ 50 % en poids d'hydroxymatairésinol, about 25% to about 50% by weight of hydroxymatairsinol,
- environ 5 % à environ 15 % en poids de laricirésinol, et about 5% to about 15% by weight of lariciresinol, and
- environ 5 % à environ 15 % en poids de sécoisolaricirésinol, about 5% to about 15% by weight of secoisolariciresinol,
par rapport au poids total de l'extrait. relative to the total weight of the extract.
5. Composition selon l'une quelconque des revendications 1 à 4, dans laquelle ledit extrait de partie de branche est un extrait d'arbre choisi parmi Abies alba, Picea abies, Betula pendula, Pinus sylvestris, Abies sibirica, Pinus sibirica, Abies balsamea, Thuja occidentalis, Northern white-cedar, Pinus cembra, Pseudotsuga menziesii, Larix decidua, Picea glauca, Picea mariana, Picea pingens, Abies pectinata, Abies lasiocarpa, Pinus banksiana, Pinus nigra, Pinus pinaster, Pinus resinosa, Larix lariciana, Larix sibirica, Thuja plicata, Fagus Sylvatica, Populus alba, Populus nigra, Populus tremula, Populus tremulus, Tsuga hetewphylla, Pinus contorta, Juniperus virginiana, et leurs mélanges. A composition according to any one of claims 1 to 4, wherein said branch portion extract is a tree extract selected from Abies alba, Picea abies, Betula pendula, Pinus sylvestris, Abies sibirica, Pinus sibirica, Abies balsamea , Thuja occidentalis, Northern white-cedar, Pinus cembra, Pseudotsuga menziesii, Larix decidua, Picea glauca, Picea mariana, Picea pingens, Abies pectinata, Abies lasiocarpa, Pinus banksiana, Pinus nigra, Pinus pinaster, Pinus resinosa, Larix lariciana, Larix sibirica , Thuja plicata, Fagus sylvatica, Populus alba, Populus nigra, Populus tremula, Populus tremulus, Tsuga hetewphylla, Pinus contorta, Juniperus virginiana, and mixtures thereof.
6. Composition selon l'une quelconque des revendications 1 à 4, dans laquelle ledit extrait de partie de branche est un extrait d'un résineux, de préférence choisi parmi Abies alba, Picea abies, Pinus sylvestris, Abies sibirica, Pinus sibirica, Abies balsamea, Thuja
occidentalis, Northern white-cedar, Pinus cembra, Pseudotsuga menziesii, Larix decidua, Picea glauca, Picea mariana, Picea pingens, Abies pectinata, Abies lasiocarpa, Pinus banksiana, Pinus nigra, Pinus pinaster, Pinus resinosa, Larix lariciana, Larix sibirica, Thuja plicata, Tsuga hetewphylla, Pinus contorta, Juniperus virginiana, et leurs mélanges, et encore plus préférentiellement choisi parmi Abies alba et/ou Picea abies. 6. Composition according to any one of claims 1 to 4, wherein said branch portion extract is an extract of a softwood, preferably selected from Abies alba, Picea abies, Pinus sylvestris, Abies sibirica, Pinus sibirica, Abies balsamea, Thuja occidentalis, Northern white-cedar, Pinus cembra, Pseudotsuga menziesii, Larix decidua, Picea glauca, Picea mariana, Picea pingens, Abies pectinata, Abies lasiocarpa, Pinus banksiana, Pinus nigra, Pinus pinaster, Pinus resinosa, Larix lariciana, Larix sibirica, Thuja plicata, Tsuga hetewphylla, Pinus contorta, Juniperus virginiana, and mixtures thereof, and even more preferably selected from Abies alba and / or Picea abies.
7. Composition selon l'une quelconque des revendications 1 à 6, comprenant au moins environ 0,1 , de préférence au moins environ 1 , au moins environ 5 , au moins environ 10 , et de manière encore plus préférée entre environ 10 % et 50 % en poids dudit extrait de partie de branche par rapport au poids total de la composition. The composition of any one of claims 1 to 6, comprising at least about 0.1, preferably at least about 1, at least about 5, at least about 10, and even more preferably at least about 10%. 50% by weight of said branch portion extract relative to the total weight of the composition.
8. Composition selon l'une quelconque des revendications 1 à 7, dans laquelle la ladite composition est une composition topique ou dermatologique. 8. Composition according to any one of claims 1 to 7, wherein said composition is a topical or dermatological composition.
9. Composition selon l'une quelconque des revendications 1 à 8, dans laquelle ladite composition est sous la forme d'un gel, d'une lotion ou d'une crème. 9. Composition according to any one of claims 1 to 8, wherein said composition is in the form of a gel, a lotion or a cream.
10. Utilisation cosmétique de la composition selon l'une quelconque des revendications 1 à 9 pour lutter contre les signes du vieillissement cutané, notamment la formation de rides, le relâchement cutané et la perte d'éclat du teint, dus en particulier à l'exposition aux UV, au tabac et/ou à la pollution et/ou pour renforcer la barrière cutanée. 10. Cosmetic use of the composition according to any one of claims 1 to 9 to combat the signs of skin aging, including the formation of wrinkles, sagging skin and loss of radiance of the complexion, due in particular to the exposure to UV, tobacco and / or pollution and / or to reinforce the skin barrier.
11. Procédé cosmétique pour lutter contre les signes du vieillissement cutané, notamment la formation de rides, le relâchement cutané et la perte d'éclat du teint, dus en particulier à l'exposition aux UV, au tabac et/ou à la pollution et/ou pour renforcer la barrière cutanée, comprenant l'application topique sur la peau de la composition telle que définie selon l'une quelconque des revendications 1 à 9.
11. Cosmetic process for combating the signs of skin aging, in particular the formation of wrinkles, sagging skin and loss of radiance of the complexion, due in particular to exposure to UV, tobacco and / or pollution and or to reinforce the cutaneous barrier, comprising the topical application to the skin of the composition as defined according to any one of Claims 1 to 9.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18735672.0A EP3638203A1 (en) | 2017-06-13 | 2018-06-12 | Cosmetic compositions comprising natural extracts and uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1755261A FR3067249B1 (en) | 2017-06-13 | 2017-06-13 | COSMETIC COMPOSITIONS INCLUDING NATURAL EXTRACTS AND THEIR USES |
FR1755261 | 2017-06-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018229410A1 true WO2018229410A1 (en) | 2018-12-20 |
Family
ID=59859219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2018/051360 WO2018229410A1 (en) | 2017-06-13 | 2018-06-12 | Cosmetic compositions comprising natural extracts and uses thereof |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3638203A1 (en) |
FR (1) | FR3067249B1 (en) |
WO (1) | WO2018229410A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117224452A (en) * | 2023-11-15 | 2023-12-15 | 露乐健康科技股份有限公司 | Mild skin care composition containing plant bud extract and its application in guarding skin barrier |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115590809A (en) * | 2022-10-20 | 2023-01-13 | 山东元裕生物科技有限公司(Cn) | Composition for repairing problem skin, preparation method and application |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10218476A1 (en) * | 2002-04-25 | 2003-11-06 | Beiersdorf Ag | Medicaments, cosmetics and dermatological compositions for a wide variety of skin treatments contain lignans or their glycosides |
US20050169947A1 (en) | 2002-06-19 | 2005-08-04 | Helena Korte | Lignan formulations |
WO2007096089A1 (en) | 2006-02-22 | 2007-08-30 | Beiersdorf Ag | Cosmetic or dermatological preparations with a content of hydroxymatairesinol for skin lightening of age spots and/or for preventing skin tanning, in particular skin tanning caused by uv radiation |
US20080124414A1 (en) * | 2003-11-12 | 2008-05-29 | Willfoer Stefan | Use Of Knotwood Extracts |
-
2017
- 2017-06-13 FR FR1755261A patent/FR3067249B1/en active Active
-
2018
- 2018-06-12 WO PCT/FR2018/051360 patent/WO2018229410A1/en unknown
- 2018-06-12 EP EP18735672.0A patent/EP3638203A1/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10218476A1 (en) * | 2002-04-25 | 2003-11-06 | Beiersdorf Ag | Medicaments, cosmetics and dermatological compositions for a wide variety of skin treatments contain lignans or their glycosides |
US20050169947A1 (en) | 2002-06-19 | 2005-08-04 | Helena Korte | Lignan formulations |
US20080124414A1 (en) * | 2003-11-12 | 2008-05-29 | Willfoer Stefan | Use Of Knotwood Extracts |
WO2007096089A1 (en) | 2006-02-22 | 2007-08-30 | Beiersdorf Ag | Cosmetic or dermatological preparations with a content of hydroxymatairesinol for skin lightening of age spots and/or for preventing skin tanning, in particular skin tanning caused by uv radiation |
Non-Patent Citations (3)
Title |
---|
BURDA; OLESZEK: "Antioxidant and anti-radical activities of flavonoids", J. AGRIC. FOOD CHEM., vol. 49, 2001, pages 2774 - 2779 |
OU B.; HAMPSCH-WOODILL M.; PRIOR R. L.: "Development and Validation of an Improved Oxygen Radical Absorbance Capacity Assay Using Fluorescein as the Fluorescent Probe", J. AGRIC. FOOD CHEM., vol. 49, no. 10, 2001, pages 4619 - 4626, XP002375231, DOI: doi:10.1021/jf010586o |
RE R.; PELLEGRINI N.; PROTEGGENTE A.; PANNALA A.; YANG M.; RICE-EVANS C.: "Antioxidant activity applying an improved ABTS radical cation decolorization assay", FREE RADICAL BIOLOGY & MEDICINE, vol. 26, no. 9, 1999, pages 1231 - 1237, XP055036352, DOI: doi:10.1016/S0891-5849(98)00315-3 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117224452A (en) * | 2023-11-15 | 2023-12-15 | 露乐健康科技股份有限公司 | Mild skin care composition containing plant bud extract and its application in guarding skin barrier |
CN117224452B (en) * | 2023-11-15 | 2024-03-22 | 露乐健康科技股份有限公司 | Mild skin care composition containing plant bud extract and its application in guarding skin barrier |
Also Published As
Publication number | Publication date |
---|---|
FR3067249A1 (en) | 2018-12-14 |
FR3067249B1 (en) | 2020-07-31 |
EP3638203A1 (en) | 2020-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1820492B1 (en) | Protecting, regenerating composition | |
LU100904B1 (en) | COSMETIC COMPOSITION INCLUDING A PASSIFLORE EXTRACT AND EDELWEISS CELLS AND USES | |
FR2918570A1 (en) | DIGLYCATION OF AGEs. | |
EP4099975A1 (en) | Method for obtaining an aqueous extract of lavender, compositions comprising such an extract and their cosmetic uses | |
EP1282395A1 (en) | Use of ellagic acid as anti-pollution cosmetic agent | |
EP3269426B1 (en) | Extract of aesculus hippocastanum | |
FR2779645A1 (en) | COMPOSITIONS FOR COSMETIC OR DERMOPHARMACEUTICAL USE CONTAINING A MIXTURE OF GREEN COFFEE AND SHEA BUTTER EXTRACT | |
EP3478368A1 (en) | Composition for combating the signs of ageing of the skin and hair and nails | |
EP3579929B1 (en) | Marsdenia cundurango | |
WO2018229410A1 (en) | Cosmetic compositions comprising natural extracts and uses thereof | |
FR3051369B1 (en) | BEET HINT EXTRACTS, COMPOSITIONS AND USES | |
EP0954280A1 (en) | Use of an extract of terminalia catappa | |
EP2431356B1 (en) | Peptidomimetic methionine derivatives as well as their use in the protection of skin cells | |
EP0946140A1 (en) | Use of an extract of cordia dichotoma | |
WO2019077268A1 (en) | Cosmetic composition for active prevention of the signs of ageing | |
FR2950532A1 (en) | PROCESS FOR THE PREPARATION OF AN EXTRACT OF PLANTS OF THE GENUS SCLEROLOBIUM, COSMETIC AND PHARMACEUTICAL COMPOSITION COMPRISING THIS EXTRACT AND THE USE OF SAID EXTRACT | |
FR3076461A1 (en) | Cosmetic composition of active prevention signs of age. | |
EP3826725B1 (en) | Use of an essential oil of white fir tree branches to combat the signs of skin ageing | |
FR3066118A1 (en) | EDULATED SECUMUM EXTRACT TO FIGHT THE HARMFUL EFFECTS OF ULTRAVIOLET RADIATION | |
JP2023128847A (en) | Active oxygen scavenger, glycation inhibitor, carbonylation inhibitor, nitration inhibitor, ages decomposer, carbonylated proteolytic agent, nitrated proteolytic agent | |
EP2039341B1 (en) | Cosmetic compositions comprising thiazolidine derivatives for use against the consequences of oxidising stress of the skin | |
JP2021147335A (en) | Nitrated protein decomposer | |
EP3229923A1 (en) | Cosmetic use of an extract of eschscholtzia californica | |
FR2757394A1 (en) | Cosmetic composition containing Guioa extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18735672 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2018735672 Country of ref document: EP Effective date: 20200113 |